A COMPREHENSIVE PIPELINE FOR CLASS COMPARISON AND CLASS PREDICTION IN CANCER RESEARCH by E. Landoni
  
UNIVERSITÀ DEGLI STUDI DI MILANO 
 
 
 
 
SCUOLA DI DOTTORATO 
Scienze biomediche cliniche e sperimentali 
 
DIPARTIMENTO 
Dipartimento di Scienze Cliniche e di Comunità 
 
CURRICULUM /CORSO DI DOTTORATO  
Statistica biomedica - ciclo XXVIII 
  
 
TESI DI DOTTORATO DI RICERCA 
 
A COMPREHENSIVE PIPELINE FOR  
CLASS COMPARISON AND CLASS PREDICTION IN CANCER RESEARCH 
 
SETTORE SCIENTIFICO-DISCIPLINARE 
MED/01 
 
 
 
 
 
CANDIDATO: DR. ELENA LANDONI 
  
 
 
TUTOR: DR. ROSALBA MICELI 
 
CO-TUTOR: DR. FEDERICO AMBROGI 
 
COORDINATORE: PROF. ADRIANO DECARLI 
 
 
 
 
 
 
 
 
 
 
A.A. 2014/2015 
ii 
 
iii 
 
Contents 
 
Abstract ......................................................................................................... v 
Acknowledgements .......................................................................................... vi 
 
1. Introduction ........................................................................................ 1 
1.1 The EDERA project ............................................................................................ 1 
1.2 Past and present research activities ....................................................................... 1 
 
2. Class comparison analysis ................................................................................ 2 
2.1 Location tests .................................................................................................. 4 
2.1.1 Student’s and Welch’s t tests .................................................................................. 4 
2.1.2 Wilcoxon-Mann-Whitney test ................................................................................... 5 
2.2 Tests for the location-scale problem ....................................................................... 6 
2.2.1 Podgor-Gastwirth PG2 test ..................................................................................... 6 
2.2.2 Cucconi test ....................................................................................................... 7 
2.3 Tests for the general two-sample problem ................................................................ 8 
2.3.1 Kolmogorov-Smirnov test ....................................................................................... 8 
2.3.2 Cramer-von Mises test ........................................................................................... 9 
2.3.3 Anderson-Darling test ........................................................................................... 9 
2.3.4 Zhang tests ...................................................................................................... 10 
2.4 Simulation study on parametric and nonparametric two-sample tests for feature screening ... 12 
2.4.1 Simulation settings ............................................................................................. 12 
2.4.2 Simulation results .............................................................................................. 14 
2.4.3 Real data example ............................................................................................. 16 
2.4.4 Final remarks ................................................................................................... 19 
2.5 Combined use of t and Anderson-Darling tests .......................................................... 20 
 
3. Class prediction analysis ................................................................................ 22 
3.1 First step: feature selection ................................................................................ 22 
3.1.1 Prediction Analysis for Microarrays ......................................................................... 22 
3.1.2 Random Forest .................................................................................................. 24 
3.1.3 Support Vector Machines ...................................................................................... 30 
3.2 Second step: classifier development ...................................................................... 39 
3.2.1 Linear Support Vector Machines ............................................................................. 40 
3.2.2 Cross Validation procedure ................................................................................... 42 
3.3 Presentation of results ...................................................................................... 44 
3.3.1 The ‘egg-shaped’ plot ......................................................................................... 44 
3.3.2 The ‘ROC space’ plot .......................................................................................... 45 
iv 
 
3.4 The Cineca system ........................................................................................... 46 
 
4. A comprehensive pipeline for class comparison and class prediction ......................... 47 
 
5. Real data applications ................................................................................... 48 
5.1 Plasmatic microRNA data ................................................................................... 48 
5.2 Secondary ElectroSpray Ionization-Mass Spectrometry data .......................................... 61 
 
6. Conclusions ............................................................................................... 72 
 
7. References ................................................................................................ 74 
7.1 References for plasmatic microRNA data ................................................................. 79 
7.2 References for Secondary ElectroSpray Ionization-Mass Spectrometry data ....................... 82 
 
Appendix 1: R codes for Cramer-von-Mises – Podgor-Gastwirth PG2 – Cucconi – Zhang tests 85 
Appendix 2: Density distributions and Empirical Cumulative Distribution Functions of the 
simulation patterns I-VI .................................................................................... 89 
Appendix 3: Simulation results in terms of size and power (α = 0.05) .......................... 109 
Appendix 4: Real data example: exemplificative kernel density distributions of selected 
‘gray-zone’ genes in ER positive (in red) and ER negative (in green) subjects................. 117  
 
v 
 
Abstract 
 
Personalized medicine is an emerging field that promises to bring radical changes in healthcare 
and may be defined as “a medical model using molecular profiling technologies for tailoring the 
right therapeutic strategy for the right person at the right time, and determine the 
predisposition to disease at the population level and to deliver timely and stratified prevention”. 
The sequencing of the human genome together with the development and implementation of 
new high throughput technologies has provided access to large ‘omics’ (e.g. genomics, 
proteomics) data, bringing a better understanding of cancer biology and enabling new 
approaches to diagnosis, drug development, and individualized therapy. ‘Omics’ data have the 
potential as cancer biomarkers but no consolidated guidelines have been established for 
discovery analyses. In the context of the EDERA project, funded by the Italian Association for 
Cancer Research, a structured pipeline was developed with innovative applications of existing 
bioinformatics methods including: 1) the combination of the results of two statistical tests (t and 
Anderson-Darling) to detect features with significant fold change or general distributional 
differences in class comparison; 2) the application of a bootstrap selection procedure together 
with machine learning techniques to guarantee result generalizability and study the 
interconnections among the selected features in class prediction. Such a pipeline was 
successfully applied to plasmatic microRNA, identifying five hemolysis related microRNAs and to 
Secondary ElectroSpray Ionization-Mass Spectrometry data, in which case eight mass 
spectrometry signals were found able to discriminate exhaled breath from breast cancer patients 
from that of healthy individuals. 
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1. Introduction 
 
1.1 The EDERA project 
 
The present research is integrated within a multidisciplinary project funded by the Italian 
Association for Cancer Research (AIRC), i.e. the EDERA (Early DEtection and Risk Assesment) 
project [1]. The project title is ‘Tumor microenvironment-related changes as new tools for early 
detection and assessment of high-risk diseases’ and it is aimed at investigating the following 
topics: 1. relevance of bone marrow-related cells and molecules for early diagnosis and risk 
assessment; 2. diagnostic value of signals from tumor microenvironment and extracellular 
matrix; 3. tumor-microenvironment interactions and genetic risk; 4. clinical impact of tumor-
microenvironment related changes. Therefore this project will provide a proof-of-concept that 
early stroma modifications in the tumor and in its microenvironment have biological and clinical 
relevance for the early detection of cancer lesions and for the early identification of aggressive 
tumors. From a statistical point of view, the aim is to construct and validate diagnostic, 
prognostic and predictive blood and tissue-based biomarkers; this can be useful for diagnosing 
cancer in its earliest stages, diagnosing cancer relapses, or indicating sensitivity to molecular 
drugs.   
 
1.2 Past and present research activities 
 
Because of the complexity of EDERA project purposes, several types of ‘omics’ (e.g. genomics 
and proteomics) data were analyzed. Specifically, during the three years of the Ph.D., we 
examined plasmatic microRNAs (miRNAs), Liquid Chromatography-Mass Spectrometry (LC-MS) 
data, immunohistochemistry (IHC), Fluorescent Activated Cell Sorting (FACS) data and Enzyme-
Linked ImmunoSorbent Assay  (ELISA) data. This research area is characterized by data with a 
huge number of variables (herein indicated as ‘features’) assessed in small samples and, from a 
more general point of view, can be seen as high dimensional data. This issue encouraged us to 
use traditional statistical methods together with ones specifically addressed to high dimensional 
data. The Unit for Statistical Coordination of the Studies I work in provides methodological and 
practical support to the different Work Packages (WPs) involved in the EDERA project. During 
the first two years of the Ph.D., besides performing applied statistical analyses together with 
methodological insights, I mainly focused on class comparison analysis and set up a simulation 
study on parametric and nonparametric two-sample tests for feature screening. We considered 
the following tests: Student’s t, Welch’s t, Wilcoxon-Mann-Whitney (WMW), Kolmogorov-Smirnov 
(KS), Anderson-Darling (AD), Cramér-von Mises (CvM), Podgor-Gastwirth PG2, Cucconi and Zhang 
tests (ZK, ZC and ZA) (chapter 2). During the third year of Ph.D., I focused on class prediction 
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analysis, both methodologically (chapter 3) and with real data applications (chapter 5). The final 
result of my Ph.D. project consists in a comprehensive pipeline for class comparison and class 
prediction analyses (chapter 4), flexible enough to adapt to different types of ‘omics’ data. In  
detail, my research activity is summarized in the following Table. 
 
 
 
2. Class comparison analysis 
 
Class comparison analysis is mainly directed to find the features differentially expressed (DE) 
between two conditions. A significance threshold above which a feature is declared 
differentially expressed has to be established. To this aim, statistical tests are needed, requiring 
the definition of appropriate test statistics and the control of the level of the tests.  
Parametric and nonparametric two-sample tests are applied in a large number of high-
dimensional continuous data for explorative studies in order to detect DE features (genes, 
miRNAs, metabolites) between different biomedical conditions, such as diseased (cases) and 
healthy subjects (controls). In particular, the tests are exploited as univariable feature ranking 
methods in class comparison ([13]), as well as a preliminary step - feature screening- in class 
prediction ([14]). Such a screening is intended to identify promising features to be possibly 
included in a multivariable model, referred to as the predictor or classifier, which aims at 
accurately predicting the class membership of a new sample based on a combination of 
expression levels of the selected features. The most commonly used tests are the t tests [15] 
and the nonparametric Wilcoxon-Mann-Whitney test [16], which refer to differences in terms of 
Area Aim/Issue Statistical method/Programming tool 
Data  
pre-processing 
Normalization with circulating miRNA data  Ratio-based normalization method [2] 
Batch effect correction ComBat method [3] 
Balancing groups in the design phase Caliper Propensity Score Matching [4] 
Concordance analysis Concordance correlation coefficient [5] 
Optimal cutoff search Index Score [6] 
Class 
comparison 
Under-detected MS data Tobit model [7] 
Search for differentially expressed (DE) features Tests for the general two-sample problem 
[8] 
Feature ranking in survival analysis Generalized Boosted Model (GBM) [9] 
Class prediction Feature selection and classifier development Two-step strategy: bootstrap feature 
ranking with three algorithms - Prediction 
Analysis for Microarrays, Random Forest,  
Elastic Smoothly Clipped Absolute 
Deviation Support Vector Machines (SVM) 
+ classifier development with Linear 
(SVM) model [10] 
Miscellaneous 
analyses 
Association studies with non normal data Quantile regression model [11] 
Computational time reduction Parallel programming 
Reproducible research: dependence of results 
on pseudorandom seeds 
Random Number Generator (RNG) [12] 
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location and therefore are classified as location tests. However, feature distributions in the 
comparison classes may differ according to other aspects such as scale or, more generally, 
shape. One could test for location or scale changes (location-scale problem) or look for any 
changes in location, scale or shape (general two-sample problem) ([17]). Even small signals of 
general differences between the two classes could reveal discriminative features that should not 
be filtered out in the first phases of bioinformatics analyses, but further investigated in the 
following step of class prediction. Moreover, the parametric test assumption of normality is 
often not fulfilled when dealing with some types of genomic data, mainly due to the small 
sample size ([18]), producing skewed, heavy-tailed or multimodal distributions of expression 
values. In presence of such distributions, nonparametric alternatives to location tests e.g. the 
Kolmogorov-Smirnov filter proposed by [19], could be more sensitive in feature screening, thus 
leading to a small number of false negative discoveries. In the field of high dimensional data, 
feature screening should not be tailored on specific distributional characteristics but rather be a 
flexible procedure, i.e. able to detect general differences between feature distributions under 
different patterns. Thus, a desirable test should prove to be robust in terms of Type I error 
control and powerful in a wide family of distributional patterns, even if not being the best one in 
every single situation. Previous studies compared via simulation limited ([17]) or specific (i.e. 
directed to show a specific type of difference ([20]; [21])) sets of two-sample tests. The above 
scenario prompted us to conduct an extensive simulation study with small sample sizes and non 
normal distributions, involving a wide set of parametric and nonparametric tests for two class 
comparison, which were compared according to their size (i.e. type I error rate) and power, 
with the aim of possibly identifying a test to be used in the screening phase of high dimensional 
explorative studies. We investigated a series of nonparametric tests considering different 
alternatives versus the null hypothesis of equality between the Cumulative Distribution 
Functions (CDFs). Being aware that when the parametric tests assumptions are violated their 
power is deflated, our aim was to assess possible nonparametric alternatives and comparatively 
draw indications of possible improvements over the parametric tests. In particular, we 
implemented the following nonparametric tests: 
 
- the Wilcoxon-Mann-Whitney (WMW) test, detecting shifts in location between the CDFs; 
 
- two tests for the location-scale problem, i.e. the PG2 Podgor-Gastwirth (PG2) [22]) and the 
Cucconi test ([20]; [23]); the PG2 test has been recognized as the most powerful among the PG 
efficiency robust tests, while the Cucconi test represents the simplest and best performing 
alternative to PG2 ([20]); 
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- three chi-squared statistic-based tests, i.e. the Kolmogorov-Smirnov (KS)([24]), the Cramer-von 
Mises (CvM) ([25]) and the Anderson-Darling (AD) ([26]) test; the KS test refers to the CDF 
maximum difference, the CvM test considers differences over the entire CDF range, while the AD 
test takes into account global CDF differences, granting more importance to the observations in 
the tails; the latter characteristic makes the AD test valuable when one is interested in finding 
also signals that are only present in a subset of patients; 
 
- the Zhang ZK, ZC and ZA tests, which are 'likelihood-ratio' based analogs of the 'traditional' KS, 
CvM and AD tests, respectively ([17]).  
 
As regards the simulation study, we chose to mimic the irregular pattern of the feature 
distributions of the two samples by using mixtures of two normal distributions (NM), which 
should reproduce the coexisting presence of heterogeneous subpopulations underlying data, by 
varying the mixture parameters. In paragraphs 2.1, 2.2 and 2.3, we briefly describe the 
considered tests; the simulation settings and results (i.e. the comparison of the tests in terms of 
size and power under different distributional patterns) are reported in paragraph 2.4. In 
paragraph 2.5 it is illustrated the combined use of t and AD tests, with an application to 
plasmatic miRNA data (described in paragraph 5.1).  
 
We can classify the investigated tests into three categories: I. location tests (Student's t, Welch's 
t, WMW), II. tests for the location-scale problem (PG2, Cucconi) and III. tests for the general 
two-sample problem (KS, CvM, AD, ZK, ZC, ZA).  
In the following, let x1,...xm and y1,...yn be the observations drawn from two independent 
random variables X and Y with continuous CDFs F(x) and G(y), respectively. 
 
2.1 Location tests 
 
The location tests assess whether the center of the data is the same for the two distributions. 
 
2.1.1 Student’s and Welch’s t tests 
 
Let μ1 and μ2 be the means and σ1
2 and σ2
2 be the variances of the random variables X and Y. The 
null and alternative hypotheses of the considered parametric tests are: 
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The t test is defined as 
 
 
and assumes that σ1
2 = σ2
2, thus estimating the pooled sample variance as 
 
 
The Welch’s t variant (Satterthwaite -Welch adjustment) assumes σ1
2 ≠ σ2
2, and is defined 
as 
 
 
Both the tests were performed using the t.test function included in the stats package. 
 
 
2.1.2 Wilcoxon-Mann-Whitney test 
 
The WMW test considers shifts in location between the two CDFs: 
 
 
 
 
Let R1 and R2 be the sums of the ranks for the observations in the two groups, U = min(U1,U2), 
where U1 = R1 - [m(m+1)/2] and U2 = R2 - [n(n+1)/2]. 
For m ≥ 8 and n ≥ 8, a normal approximation is used to calculate the standardized WMW test 
statistic: 
 
 
The WMW test considers the differences between the two distributions in terms of shifts in 
location, i.e. the null hypothesis is rejected if there is a prevalence of high ranks (or low ranks) 
in one group. The test was performed using the wilcox.test function included in the stats 
package. 
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2.2 Tests for the location-scale problem 
 
The tests for the location-scale problem assess whether both the samples come from the same 
distribution: 
 
 
against the location-scale alternative hypothesis: 
 
with μ ≠ 0 or σ ≠ 1. 
 
2.2.1 Podgor-Gastwirth PG2 test 
 
Let Ii, i = 1,...,N be a group indicator so that Ii = 1 when the i
th element of the combined sample 
belongs to the first sample, Ii = 0 otherwise; let Si and Si
2 be the ranks and the squared ranks of 
the observations in the combined sample (i=1,...,N). The PG2 test statistic is calculated as the 
ordinary least squares (OLS) estimator of Si and Si
2 on the group indicators Ii and is distributed as 
a Fisher-Snedecor F with 2 and N-3 degrees of freedom: 
 
 
 
In the above formula, T denotes the transpose operator, b is the 3 x 1 vector of the OLS 
estimate of the intercept term and the regression coefficients, S the N x 3 matrix of the ranks 
and the squared ranks of the observations and I the N x 1 vector of the group indicators I1,..., IN: 
 
 
 
Large values of the statistic imply the rejection of H0. Podgor and Gastwirth showed that 
asymptotically the PG2 test can be recast as a quadratic combination of the Wilcoxon rank test 
for location and the Mood squared rank test for scale (Mood's scores give more weight to the 
extreme ranks). 
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2.2.2 Cucconi test 
 
The Cucconi test addresses the location-scale problem by using the squares of ranks (Si) and 
contrary-ranks (N+1- Si) of the observations of the sample Xi (i=1,...,m) computed in the pooled 
sample. The test statistic is defined as: 
 
 
 
where: 
 
 
 
 
 
Note that U is based on the squares of the ranks Si, while V is based on the squares of the 
contrary-ranks (N + 1 - Si) of the first sample. Let U' and V' be U and V computed referring to the 
second sample Yj (j=1,...,n); the aforementioned expressions of U and V become, respectively: 
 
 
 
 
 
Since 
 
 
then U' = -U and V' = -V. Thus, the two test statistics are equal: 
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It makes no difference whether U and V are computed based on the data of the first or the 
second sample, since this choice does not modify the test statistic. Large values of the statistic 
imply the rejection of H0. For the asymptotic Cucconi test we used the reported critical 
threshold of -ln(α).  
 
2.3 Tests for the general two-sample problem 
 
Like the WMW test and the tests for the location-scale problem, the tests for the general two-
sample problem assess whether both samples come from the same distribution: 
 
                
 
However, the alternative hypothesis is: 
 
 
and thus it evaluates general differences between the two CDFs. The KS test concentrates on 
local CDF shifts while the CvM and AD tests consider the differences all along the CDF 
distribution. 
 
2.3.1 Kolmogorov-Smirnov test 
 
The KS test statistic is defined as the largest absolute value of the difference between the 
Empirical Cumulative Distribution Functions (ECDFs) of the two samples: 
 
 
 
For large sample sizes, i.e. m = n with n > 40 (balanced sample sizes) and m > 16 and n > 20 
(unbalanced samples), the large sample approximation is used ([27]) and the null hypothesis is 
rejected at level α when: 
 
for balanced sample sizes, or 
 
 
for unbalanced sample sizes, where c(α) are tabulated values ([27] - Tables 16 and 17). The test 
was performed using the ks.test function included in the stats package. 
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2.3.2 Cramer-von-Mises test 
 
The CvM test considers the difference between the two distributions over the entire CDF range. 
The L2-norm based version of the CvM test, which was introduced by Anderson et al. ([25]) and 
involves the quadratic distance between the two ECDFs, was considered. Let NHN(x,y) = mFm(x) + 
nGn(y), being HN the ECDF associated with the combined sample. Then the CvM test statistic is 
defined as: 
 
which is equivalent to: 
 
 
 
The null hypothesis is rejected for large values of CvM; asymptotic critical values are reported 
by Anderson and Darling [25]. However, the distance between the two ECDFs tends to 0 when x 
→  - ∞ or x → + ∞, thus the value of the CvM test statistic is rather insensitive to the 
differences in the distribution tails. We performed the test by implementing a user-defined 
function including the empirical correction formula reported by Burr ([28]), using the limiting 
distribution to approximate the exact distribution of the CvM test statistic. 
 
2.3.3 Anderson-Darling test 
 
The AD test statistic is a modification of L2-CvM test statistic that, in order to give more weight 
to the observations in the distribution tails, includes a weighting function equal to the reciprocal 
of the variance of the ECDF (the latter is maximal around the median and minimal in the tails): 
 
 
 
A simplification was introduced for computational purposes: 
 
 
where Mi is defined as the number of observations in the first sample less than or equal to the i
th 
smallest in the pooled sample. The standardized statistic is obtained by using its exact mean 
(equal to 1 in case of two samples), and exact variance σN, which was derived by Scholz ([26]): 
10 
 
 
 
The upper tail critical values for the aforementioned test statistic are reported by Scholz ([26]) 
and the null hypothesis is rejected for large values. The standardization removes some of the 
dependence of the test on the sample size, as it was confirmed through a Monte Carlo study 
([26]). For not tabulated critical values, an interpolation formula may be used to obtain the 
percentiles of interest. The test was performed using the adk.test function included in the adk 
package. 
 
2.3.4 Zhang tests 
 
All the considered Zhang tests (ZK, ZC, ZA) derive from two types of test statistics ([29]) defined 
as: 
 
 
and 
 
 
where Zt is the likelihood ratio test statistic and w(t) is a weighting function characterizing the 
different tests. The Zhang tests are the analogs of the traditional tests KS, CvM and AD, which 
are obtained using the Pearson χ2 test statistic as Zt. 
 
Zhang ZK test.  
ZK is the analog of the KS test and it is obtained from Zmax with w(t) = 1. The computational 
formula for the ZK test statistic is: 
 
 
where 
 
 
and HN denotes the ECDF of the pooled sample (k=1,...,N). Large values of the statistic guide to 
the rejection of H0.  
 
Zhang ZC test.  
ZC is the analog of the CvM test and it is obtained from Z with dw(t) defined as: 
11 
 
 
 
where F(t) is the common underlying distribution under H0. Let R1 denote the rank in the pooled 
sample of the ith-ordered statistic X(i) in the first sample Xi (i=1,...,m) and R2 denote the rank in 
the pooled sample of the jth-ordered statistic Y(j) in the second sample Yj (j=1,...,n). The 
computational formula for the ZC test statistic is: 
 
Small values of the statistic guide to the rejection of H0. 
 
Zhang ZA test.  
ZA is the analog of the AD test and it is obtained from Z with dw(t) defined as: 
 
 
 
The computational formula for the ZA test statistic is: 
 
 
 
Small values of the statistic guide to the rejection of H0.  
 
R codes of user-defined functions for the implementation of PG2, Cucconi, CvM and Zhang tests 
are reported in the Appendix 1. 
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2.4 Simulation study on parametric and nonparametric two-
sample tests for feature screening 
 
2.4.1 Simulation settings 
 
A simulation study was conducted in order to compare the performance - in terms of size and 
power - of the tests previously described under different distributional patterns. Following the 
considerations made by Burton et al.([30]), we decided to simulate data with some resemblance 
to real continuous high dimensional data, replicating their irregular distributional patterns by 
using mixtures of two normal distributions (NM) (Figure 1).  
Let μiA and μiB be the means of the two components A and B of the mixture in the sample i 
(i=1,2), with μiB - μiA = shi (shift), σiA
2 and σiB
2 be the mixture variances and λi the mixture weight, 
which is the probability associated with the first component of the mixture. Finally, let δ = μ2 - 
μ1 be the difference between the two overall mixture means in the two samples, with μi = λiμiA + 
(1 - λi)μiB. Three main cases were simulated: A. two normal distributions; B. one normal and one 
mixture distributions; C. two mixture distributions; a particular sub-case with equal shifts sh1 = 
sh2 = sh was also considered. The parameters δ, sh1, sh2 were properly tuned over fixed ranges in 
order to simulate the different conditions under H0 and H1. We considered four mixture weights 
λ Є {0.80; 0.95; 0.20; 0.05} and three small sample size settings, one balanced (m=20 vs n=20) 
and two unbalanced (m=20 vs n=40 and m=40 vs n=20) (Table 1). We fixed σ1A
2 = σ1B
2 = σ2A
2 = σ2B
2 
= 1; this is not a limitation since the mixture overall means μ1 and μ2 will not be constant but 
will vary according to sh1 and sh2, as well as the mixture overall variances σ1
2 and σ2
2 which will 
change according to shifts and mixture weights.  
 
Figure 1. Example figure of two normal mixture distributions setting adopted into the simulation. μiA and μiB are the 
means of the two components A and B of the mixtures in the two samples i (i=1,2) with shifts shi = μiB - μiA (i=1,2), δ = 
μ2 - μ1 is the difference between the two mixture overall means and λi are the two mixture weights of the A 
components, being their complement the mixture weights of the respective B components. 
13 
 
 
Table 1. Ranges of values for the parameters λ, δ, sh and (m,n). 
 
We distinguished six different patterns, summarized in Table 2 and graphically represented in 
the Appendix 2 for each combination of sample size settings and mixture weights. We chose to 
consider a nominal significance level α = 0.05 and to perform B = 10000 simulations so as to 
obtain precise estimates derived via the simulation. As an indicator of the simulation error we 
chose the standard error SE(p), with p indicating the nominal coverage probability ([30]). 
Finally, we calculated the relative frequencies of H0 rejection of the tests; under H0 such 
frequencies are expected to approximate the fixed nominal significance level α, while under H1 
they correspond to the empirical power of the tests. It was possible to simulate the null 
hypothesis patterns only when comparing two normal distributions with equal means (pattern I) 
or two perfectly overlapping mixture distributions, i.e. those with equal shifts (pattern IV). The 
robustness of the tests under H0 was evaluated according to the indications given by both 
Conover ([31]) and Marozzi ([32]): a test is considered robust if its Maximum Estimated 
Significance Level (MESL), i.e. its maximum relative frequency of H0 rejection under H0 (Table 2 
- H0 patterns) does not exceed a given threshold, typically 2α or 1.5α to be more restrictive.  
 
 
 
Table 2. The six selected patterns under null (H0) and alternative (H1) hypotheses. I. two normals; II. normal vs 
mixture (sh = 6); III. mixture (sh = 6) vs normal; IV. two mixtures with equal shifts (sh1=sh2 = 6); V. two mixtures with 
different shifts (sh1 = 3 < sh2 = 6); VI. two mixtures with different shifts (sh1 = 6 > sh2 = 3). Abbreviations: N = Normal 
distribution; NM = Mixture of Normal distributions. 
 
As regards the nonparametric tests, exact p-values have been computed for the KS test, while 
for the WMW, PG2, Cucconi, CvM and AD tests we report the asymptotic p-values. For the CvM 
test we used the p-values tabulated by Anderson et al. ([25]), since it has been shown that under 
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H0 the two-sample statistic has the same limiting distribution as that of the one-sample statistic 
([33]). Moreover, using the Burr's formula, we can obtain the p-values corresponding to all the 
possible values of the CvM statistic and not limited to the tabulated ones; it is reported that 
such an approximation works to the fifth decimal place for values of the statistic between 0.42 
and 2.2, and we empirically verified that, for values of the statistic greater than 0.10308, the 
formula approximates up to the second decimal place the p-values tabulated by Anderson et al. 
([25]). Moreover, values of the statistic below 0.10308 correspond to p-values higher than 0.57, 
which are of no interest here since they indicate non significant features. Finally, for the three 
Zhang tests, as well as for the Cucconi test as an alternative to the asymptotic version, we used 
the Monte Carlo approach to find the corresponding approximate empirical p-values (size = 2000 
simulations). The tests were applied with no correction for ties since the considered data are 
continuous and do not have tied values. The rnormmix function from the mixtools package was 
used to simulate the mixtures of univariate normal distributions. Because of the computational 
burden of the simulation, parallel programming (using the two packages doParallel and doRNG) 
was implemented in order to perform simultaneous and reproducible computations. 
 
 
2.4.2 Simulation results 
 
A complete report of the simulation results is shown in the Appendix 3. Given 10000 simulations, 
the chosen 5% significance level provided a SE equal to 0.2%, which is the simulation error for 
the H0 patterns; as regards the power, in the worst situation when it is equal to 50%, the SE 
would be equal to 0.5%. Therefore, we got a precision of simulation estimates up to the third 
decimal. All the tests resulted robust according to both Conover and Marozzi indications, since 
relative frequencies of H0 rejection under H0 (patterns I and IV) were less than 0.1 and 0.075 
respectively; the maximum frequency was 0.063 for the ZK test, when λ = 0.95 and (m,n) = 
(20,20); the KS test was the only one with frequencies lower than 0.05 in most situations, 
reaching a minimum of 0.034, when λ = 0.80 and (m,n) = (20,20). As regards the power, we did 
not find a clear winner for all the patterns; in general, within the same category (location, or 
location-scale, or general two-sample problem) the tests shared similar power for all the 
considered patterns, except for KS and ZK which showed to be very conservative tests. Moreover, 
as expected, the tests for the general two-sample problem were generally more sensitive than 
those for the location-scale problem, especially when λ = 0.95. As an example to visualize the 
overall advantage brought by the general two-sample problem tests, we report the results in 
terms of power under the patterns I-VI, having fixed δ = 1 and m = 20 vs n = 20 and with λ = 0.80 
(Figure 2) and λ = 0.95 (Table 3). 
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Figure 2. Barplots of power of the considered two-sample tests for the six selected scenarios with δ=1, λ=0.80 and 
(m,n) = (20,20). I. two normals; II. normal vs mixture (sh=6); III. mixture (sh=6) vs normal; IV. two mixtures with equal 
shifts (sh1=sh2=6); V. two mixtures with different shifts (sh1=3 < sh2=6); VI. two mixtures with different shifts (sh1=6 > 
sh2=3). All mixtures have λ = 0.80. The tests are sorted in descending order according to the power. The different 
colors indicate the three types of tests (location tests in black, tests for the location-scale problem in gray and tests 
for the general two-sample problem in lightgray). 
 
 
 
Table 3. Power estimates with α=0.05, δ=1, λ=0.95 and (m,n) = (20,20). Location tests: t = Student's t test; Welch = 
Welch's t test; WMW = Wilcoxon-Mann-Whitney test. Location-scale tests: PG2 = Podgor-Gastwirth PG2 test; C = 
Cucconi test (asymptotic version); C.emp = Cucconi test (empirical version). Tests for the general two-sample 
problem: KS = Kolmogorov-Smirnov test; CvM = Cramer-von Mises test; AD = Anderson-Darling test; ZK = Zhang ZK test; 
ZC = Zhang ZC test; ZA = Zhang ZA test. 
 
With both mixture weights, the two parametric location tests (Student's t and Welch's t) headed 
the power ranking in case of two normal distributions (pattern I) or when the second distribution 
was a mixture (pattern II); in the latter case their ability lied in detecting the observations in 
the tail of the mixture. However, when the two ECDFs were crossing, i.e. when the two 
distributions overlapped at certain points, their power collapsed (see Figures A2 in the Appendix 
2, patterns III, IV, VI). The location tests (Student's t, Welch's t and WMW) generally showed a 
high power for pattern V, where the two ECDFs of the mixtures appeared mostly separated, and 
thus the differences between the two samples were mainly in terms of location. The 
nonparametric location test, i.e. the WMW, was more powerful than the parametric tests in the 
patterns involving two mixture distributions, except for pattern V and λ = 0.80 (Tables A3.1.6, 
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A3.1.7). However, it did not emerge as the best alternative to the parametric tests in presence 
of two mixture distributions, especially when λ = 0.80, where the advantage of the location-
scale and general two-sample tests was more evident. The location-scale tests (PG2 and Cucconi 
tests) showed the highest power in the patterns III and VI with λ = 0.80 (Tables A3.1.6, A3.1.8), 
corresponding to situations of scale differences being one distribution in the middle of the other 
one with ECDFs overlapping for the most part. Such tests seem to be particularly able to detect 
the differences in the peaks of the compared distributions. In general, the PG2 test was more 
powerful than the Cucconi test (both asymptotic and empirical versions) and the approximate 
empirical version of the Cucconi test was always more powerful than the asymptotic version. In 
the patterns IV and V with λ = 0.80 and the patterns III-VI with λ = 0.95 the tests for the general 
two-sample problem were generally the most powerful ones. The most liberal tests were the AD 
test, its analog ZA test, the CvM test and its analog ZC test; in particular, for mixtures with equal 
shifts (pattern IV) the AD test was the most sensitive one, together with the ZC and CvM tests. 
Moreover, when the normality assumption was fulfilled, the AD, CvM, ZA and ZC tests had a 
limited loss in power compared to that of the other nonparametric tests, while being very 
powerful in detecting any difference between the two samples in the remaining patterns. For 
example, the application of the AD test implied a loss in power of ~ 2% in pattern I, but a gain of 
~ 32% in pattern IV respect to the parametric tests (Table A3.1.6). It is worth to notice that, in 
spite of being tests for the general two-sample problem, the KS and its analog ZK proved to be 
very conservative, showing low power in all the simulated patterns. With small weights to the 
first component of the mixtures (λ = 0.20 and λ = 0.05), we obtained similar results, being the 
AD, CvM, ZA and ZC the most sensitive tests in the III-VI patterns, while still maintaining a high 
power in the I and II patterns. Respect to λ = 0.80 and λ = 0.95, the power was higher for all the 
tests and, for patterns II, III and V, it often reached the 100%. Indeed, in these cases the mixture 
distribution density is concentrated at its second component, thus yielding well separated 
distributions and easily detectable differences. Regarding the unbalanced sample size settings 
(m=20 vs n=40 and m=40 vs n=20), the dominance of the general two-sample tests remained 
evident, except for the pattern V with m=20 vs n=40 and λ = 0.80, where the Welch's t test 
resulted as the most powerful test, even if the difference in power was small (~ 4%) respect to 
the ZA test (Table A3.1.7). An explanation could be the presence of a large tail of the 
distribution of the second sample, corresponding to an evident difference between the two 
means (Figure A2.1, m=20 vs n=40, pattern V). 
 
2.4.3 Real data example 
 
As an example of the application of the considered tests to real data the dataset included in the 
R Bioconductor package breastCancerNKI was chosen, containing gene expression data as 
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published in Van't Veer et al. ([34]) and Van de Vijver et al. ([35]) (24481 genes/features 
evaluated in 337 samples). We defined two classes according to the Estrogen Receptor (ER) 
status (249 ER positive and 88 ER negative). To prevent confounding, we matched 1:1 the 
subjects on the basis of three clinical variables, i.e. age (quintile based classes), tumor size 
(quintile based classes) and tumor grade (3 classes). Thus, we obtained 33 ER positive paired 
with 33 ER negative individuals, a sample size setting in between those considered for the 
simulation study. We then used a 100% filtering (i.e. we required the detection of all features in 
all 66 samples), keeping the expression of 19264 genes. We then applied all the tests, adjusting 
for multiple testing with the Benjamini-Hochberg method ([36]) for the control of the False 
Discovery Rate (FDR). We considered a test as significant when the corresponding FDR-adjusted 
p-value was < 5%. Globally, the AD test resulted as the most 'saving-features' test, with 3512 
detected genes; then, in descending order according to the number of significant features, we 
got the CvM, WMW, ZK, ZA, Student’s t, Cucconi (empirical version), Welch’s t, PG2, ZC, Cucconi 
(asymptotic version) and the KS tests (Table 4). Over the 19264 filtered genes, 15094 were not 
significantly DE and 1842 were significantly DE for all tests. Focusing on the remaining subset of 
2328 'gray-zone' features and classifying the tests according to the three categories (location, 
location-scale and general two-sample problem), the largest number of DE features was 
detected by the WMW test for the location problem (1491 features), the Cucconi (empirical 
version) for the location-scale problem (1051 features) and the AD test for the general two-
sample problem (1670 features). The Cucconi test detected 31 features more than the PG2 test; 
however, such a slight difference could be dependent on the choice of the real data. The 
application of the nonparametric tests added 151 significantly DE features respect to the 
parametric tests. For illustration purposes the distribution of a representative feature among 
such 151 is represented in Figure 3A according to the ER status; as expected, in both ER classes 
the distributions appeared not normal (skewed and multimodal). The KS and its analog ZK acted 
differently respect to the other tests as previously seen in the simulation, since 131 features 
were detected using all tests except KS (representative feature: Figure 3B) and 84 features 
using all tests except ZK (representative feature: Figure 3C). Thirty-seven features were 
separately recognized by the location-scale tests (PG2 and Cucconi), being characterized by 
overlapped values in the two classes but with different peak magnitudes (representative 
feature: Figure 3D). 
In Figure 4 we plotted a Venn diagram considering the three most sensitive tests within each 
category according to the simulation results, i.e. the WMW test (location), the PG2 (location-
scale problem) and the AD test (general two-sample problem). 
Excluding the 781 features in common among the three tests, the AD test shared 674 features 
with the WMW test and 102 features with the PG2, while WMW and PG2 tests shared no features. 
Similar results were obtained using the Cucconi test (both versions) instead of PG2. 
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Table 4. Real data example: ranking of the tests according to the number of significantly DE features (FDR-adjusted 
p-value < 0:05). 
 
Figure 3. Real data example: exemplificative kernel density distributions of 4 selected 'gray-zone' genes in ER positive 
(in black) and ER negative (in gray) subjects. 
 
 
Thus, the tests for the location-scale problem seemed to be less concordant with the WMW 
location test. On the contrary, the AD test and the WMW test shared in all 1455 (63%) of the 
features, being the AD a more sensitive test. As expected, regarding the features separately 
identified by each of the three tests, we noticed that the 36 features detected by the WMW test 
were almost symmetric distributions and mainly differed in terms of location (Figure A4.1), 137 
features had different peak magnitudes mainly differing in terms of scale, and thus were 
significant at PG2 test only (Figure A4.2), while the distributions of the 113 features detected 
as DE by the AD test were different in general aspects, i.e. besides location and scale, they 
showed different and irregular tails (Figure A4.3). 
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Figure 4. Real data example: Venn diagram with WMW, PG2 and AD tests on the 'gray-zone' subset of features. 
  
 
2.4.4 Final remarks 
 
Two-sample tests for class comparison are often used in bioinformatics and medicine for 
exploratory purposes, i.e. to detect DE features between different biomedical conditions. The 
most commonly used are the location tests, such as the parametric t test and its variations, 
together with nonparametric tests such as the WMW test; however, they are able to detect only 
shifts in distributions and not to identify any other difference in scale or shape. The major 
drawback in applying the above tests is that the expression values of high dimensional data 
generally exhibit departures from normality and features could be DE in other aspects rather 
than location only. Indeed, they can miss features which are characterized by more general and 
subtle distributional discrepancies. These different signals might hide differential biological 
processes and have to be preserved in order to be further explored by including them in an 
multivariable model for class prediction. We set a simulation study to evaluate the performance 
of different location tests (Student's t, Welch's t, WMW), tests for the location-scale problem 
(PG2 and Cucconi) and tests for the general two-sample problem (KS, CvM, AD, ZK, ZC, ZA), by 
modeling the irregular signals by means of mixtures of two normal distributions. Although ZC in 
particular was suggested as the best one among the three ZK, ZC and ZA, we assessed the 
performance of all Zhang tests, since we wanted a complete comparison with the corresponding 
traditional tests (i.e. KS, CvM and AD). We did not find a clear winner for all considered 
distributional patterns among the tests proposed as an alternative to the most used ones. 
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However, the simulation study and the real data example showed that the tests for the general 
two-sample problem tend to save a great number of DE features, with a gain in power respect to 
the location and location-scale tests. Location tests consider DE a feature with almost symmetric 
distributions in the two compared samples, while location-scale tests are able to detect also 
differences in terms of peak magnitude. The tests for the general two-sample problem make one 
more step further introducing a more general concept of 'differential expression', thus 
overcoming the limitations of the above mentioned tests restricted to specific moments of the 
feature distributions. Specifically, the AD, CvM and their analogs ZA and ZC tests have to be 
preferred since their power was very similar to that of the more efficient parametric tests when 
the normality assumption was fulfilled, while in all the other situations they still resulted very 
powerful in detecting differences between the two samples. The AD test in particular seemed to 
be a very sensitive test in most of the simulated patterns and, accordingly, kept more features 
than any other considered test in the real data example. In conclusion, the AD test should be 
considered as a powerful alternative to the parametric tests as feature screening method in 
order to keep as many discriminative features as possible for the subsequent class prediction 
analysis. 
 
 
2.5 Combined use of t and Anderson-Darling tests 
 
Given the final remarks about the results of the simulation study (see paragraph 2.4), we 
propose the combined use of t and AD tests in order to perform the class comparison analysis 
between two classes, i.e. hemolyzed samples (cases) vs not hemolyzed samples (controls).  
 
The t test is commonly applied for class comparison being directly related to the fold change 
(FC), which gives a measure of the direction and the strength of the differential expression; 
however, this aspect could represent a limitation because only the difference between the 
means is explored. On the other hand, the AD test is able to detect more general differences 
between the two classes, which could reveal hidden differential biological processes.  
We report below an example of volcano and concordance plots (Figure 5). We considered DE the 
features for which the p-value was below the 5% level for at least one of the two tests. This 
procedure could inflate the overall Type I error; however, we expect such an effect to be 
marginal because the two tests statistics are likely to be dependent and, in addition, both the 
tests are applied to the same data.  
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Figure 5. Class comparison results: t-test volcano plots and concordance plots between t- and Anderson and Darling 
test. In the volcano plots the log2 feature fold change is plotted on the x-axis and the negative log10 p-value at t-test 
is plotted on the y-axis. The horizontal line indicates the 5% significance level, while n is the number of significantly 
up-regulated (first quadrant) and down-regulated (second quadrant) features. In the concordance plots the negative 
log10 p-value according to the AD test is plotted on the x-axis and the negative log10 p-value according to the t-test is 
plotted on the y-axis. Points lying on the dashed line would indicate perfect concordance between the two tests. 
 
Looking at the volcano plot, 104 features resulted as significantly up-regulated and 94 features 
as significantly down-regulated with the t test, for a total of 198 features. The concordance plot 
shows that 224 features were significantly at the t or AD test: 170 features were detected by 
both the tests (first quadrant of the plot in the right panel), 28 features only by the t test 
(second quadrant) and 26 features only by the AD test (fourth quadrant).  
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3. Class prediction analysis  
 
In class prediction analysis, as for the class comparison analysis, the comparison groups are 
predefined but the aim is to develop a classifier, i.e. a feature expression-based multivariable 
model able to accurately discriminate between cases and controls.  
 
3.1 First step: feature selection 
 
Repeated bootstrap samples (B=1000) [40] were drawn from the original dataset in order to 
obtain a robust ranking of features with different distribution between two classes of interest, 
on the basis of their frequency of simultaneous extraction by three machine learning selection 
algorithms on all the bootstrap samples, i.e. Prediction Analysis for Microarrays (PAM) [41], 
Random Forests (RF) with Boruta FS (feature selection) method [42] and the Elastic SCAD SVM 
[43] or, alternatively, the L1-SVM [44]. These methods were chosen since they overcome the 
‘curse of dimensionality’ usually present in high dimensional data and because the inherent 
biological dependence between the features implies correlation between features. In fact, both 
PAM and RF outperform standard SVM in the presence of correlated predictors [45], and the 
same is true for the Elastic SCAD SVM, which is a SVM variant. On the other hand, the L1-SVM is 
computationally faster than the Elastic SCAD SVM and tends to select only one feature from a 
group of correlated features, dropping the others. To guarantee the reproducibility of the 
results, the bootfs package is used, by properly modifying the doBS function. The change 
consisted in the introduction of a seed for the bootstrap sampling, in addition to the seeds for 
the classification algorithms. 
 
3.1.1 Prediction Analysis for Microarrays  
 
PAM, also called the nearest shrunken centroids, is an enhancement of the simple nearest 
centroid classifier [41]. Such a technique can be seen as a modification to the classic Linear 
Discriminant Analysis (LDA) in two aspects tailored to high dimensional and low-sample sized 
data, i.e. the regularization of the covariance matrix and the variable selection through 
shrinkage. Briefly, the method computes a standardized centroid for each class. This is the 
average expression for each feature in each class divided by the within-class standard deviation 
for that feature. Nearest centroid classification takes the feature expression profile of a new 
sample, and compares it to each of these class centroids. The class whose centroid that it is 
closest to, in squared distance, is the predicted class for that new sample. Nearest shrunken 
centroid classification makes one important modification to standard nearest centroid 
classification. It ‘shrinks’ each of the class centroids toward the overall centroid for all classes 
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by an amount, i.e. the threshold. This shrinkage consists of moving the centroid towards zero by 
threshold and setting it equal to zero if it hits zero. For example, if threshold is 2.0, a centroid 
of 3.2 is shrunk to 1.2, a centroid of -3.4 is shrunk to -1.4, and a centroid of 1.2 is shrunk to 
zero. After shrinking the centroids, the new sample is classified by the usual nearest centroid 
rule, but using the shrunken class centroids. More formally, let xij be the expression for features 
i = 1, 2, . . . p and samples j = 1, 2, . . . n. Given the classes 1, 2, . . . K, let Ck be the indices of 
the nk samples in class k. The i
th component of the centroid for class k is 
 
 
the mean expression value in class k for feature i; the ith component of the overall centroid is  
 
 
 
So, the class centroids is shrunk toward the overall centroids after standardizing by the within-
class standard deviation for each feature. This standardization has the effect of giving higher 
weight to features whose expression is stable within samples of the same class. Such 
standardization is inherent in other common statistical methods such as LDA.      
Let 
                                                                                                                    (1) 
 
where si is the pooled within-class standard deviation for feature i: 
                                              (2) 
and  
 
 
makes the mk*si equal to the estimated standard error of the numerator in dik. In the 
denominator, the value s0 is a positive constant (with the same value for all features), included 
to guard against the possibility of large dik values arising by chance from features with low 
expression levels. s0 is set equal to the median value of the si over the set of features. A similar 
strategy is used in the SAM methodology [46].Thus dik is a t statistic for feature i, comparing 
class k to the overall centroid. Equation (1) can be rewritten as 
                       (3) 
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PAM shrinks each dik toward zero, giving dik’ and yielding shrunken centroids 
 
                                                     (4) 
The shrinkage used is called soft thresholding, i.e. each dik is reduced by an amount ∆ in 
absolute value and is set to zero if its absolute value is less than zero. Algebraically, soft 
thresholding is defined by 
                                            (5) 
where + means positive part (t+ = t if t > 0 and zero otherwise). Because many of the  values 
will be noisy and close to the overall mean , soft thresholding usually produces more reliable 
estimates of the true means [47; 4848]. The shrinkage has two advantages: 1) it can make the 
classifier more accurate by reducing the effect of noisy features, 2) it does automatic FS. In 
particular, if a feature is shrunk to zero for all classes, then it is eliminated from the prediction 
rule. Alternatively, it may be set to zero for all classes except one, and therefore it means that 
high or low expression for that feature characterizes that class. The practitioner has to set the 
value to use for threshold. To guide in this choice, PAM does k-fold Cross Validation (CV) for a 
range of threshold values. The samples are divided up at random into k roughly equally sized 
parts. For each part in turn, the classifier is built on the other k-1 parts then tested on the 
remaining part. This is done for a range of threshold values and the CV misclassification error 
rate is reported for each threshold value; the threshold value which gives the minimum CV 
misclassification error rate is the chosen one. At the end a simple-to-understand classifier is 
obtained, but there are potential limitations with such a method. The main concern is that PAM 
is possibly too extreme, since the covariance matrix is restricted to be diagonal. It may be 
beneficial to differently estimate the covariance matrix; furthermore, more effective shrinkage 
schemes may be possible. 
 
3.1.2 Random Forest  
 
Bagging or bootstrap aggregation is a technique for reducing the variance of an estimated  
prediction function. The essential idea of bagging is to apply an estimator to multiple bootstrap 
samples and averaging the result across bootstrap samples, thus reducing the variance. Decision 
trees [4949] are ideal candidates for bagging, since they can capture complex interaction 
structures in the data, and if grown sufficiently deep, have relatively low bias. Since trees are 
notoriously noisy, they benefit greatly from the averaging. Moreover, the expectation of an 
average of B trees is the same as the expectation of any of them. Therefore, the bias of bagged 
trees is the same as that of the individual trees, and the only possibility of improvement is 
through variance reduction. For classification problems, a group of trees is finally constructed, 
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each tree casting a vote for the predicted class. RF is a substantial modification of bagging 
which builds a large collection of de-correlated trees and then averages them. It is among the 
most popular machine learning methods and it is often applied in the life sciences because it 
supports high dimensional datasets, is robust to large amounts of noise, requires little parameter 
tuning and demands no predictor transformation [50; 51; 52; 53]. RF also natively produces a 
feature importance measure that directly expresses the role of a feature in all interactions 
utilized in the model, including weak and multivariate ones. These characteristics make RF a 
promising classification algorithm for FS tasks [51]. RF is designed to form an ensemble of weak 
unbiased classification trees. Each tree is constructed using different bootstrap samples. Each 
bootstrap sample is a result of drawing with replacement the same number of objects as in the 
original training set. As a result, a part of objects is not used for building a tree but it is used for 
performing an Out Of Bag (OOB) error estimate and for importance measurement. At each step 
of the tree construction a different subset of features is randomly selected. The split is 
performed using the attribute which leads to the best distribution of data between nodes of the 
tree. This procedure is performed until the whole tree is built. Then the constructed tree is used 
to classify its OOB objects, and the result is used for obtaining the approximations of the 
classification error and for the computation of confusion matrices. New objects are classified by 
all trees in the forest and the final decision is made by simple voting (see below the Random 
Forest Algorithm). The importance of each feature is estimated as follows. Firstly, the 
classification of all objects is performed. The number of votes for a correct class is recorded for 
each tree. Then the values of a given feature are randomly permuted across objects, and the 
classification is repeated. The number of votes for a correct class is again recorded for each 
tree. The importance of the feature for the single tree can be then defined as a difference 
between the number of correct votes for the original and permuted system divided by the 
number of objects. The importance of the feature is then obtained by averaging importance 
measures for individual trees. The Z-score, i.e. the ratio between the average value and its 
standard deviation, can also be used as an importance measure. The advantage of the Z-score is 
that it gives more weight to a relatively small but stable decrease of classification performance. 
RF provide two straightforward measures of feature importance, i.e. Mean Decrease Impurity 
(MDI) and Mean Decrease Accuracy (MDA) [54]. Every node in the decision trees is a condition on 
a single feature, designed to split the dataset into two so that similar response values end up in 
the same set. The measure based on which the (locally) optimal condition is chosen is called 
impurity. When training a tree, it can be computed how much each feature decreases the 
weighted impurity in a tree. For a forest, the impurity decrease from each feature can be 
averaged and the features are ranked according to this measure.  
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Random Forest Algorithm 
1. For b=1 to B: 
(a) Draw a bootstrap sample Z* of size N from the training data. 
(b) Grow a random-forest tree Tb to the bootstrapped data, by recursively repeating the 
following steps for each terminal node of  the tree, until the minimum node size nmn is 
reached: 
i.  select m features at random from the p features; 
ii.  pick the best feature/split-point among the m; 
iii.  split the node into two daughter nodes. 
 
2. Output the ensemble of trees {Tb}1
B. 
To make a prediction at a new point x: 
Regression:     
 
Classification: Let  be the class prediction of the bth RF tree. Then  
 
 
In formulas, the importance of a feature Xm for predicting Y by adding up the weighted impurity 
decreases p(t)∆i(st, t) for all nodes t where Xm is used, averaged over all NT trees in the forest:  
                                  (6)          
and where p(t) is the proportion Nt/N of samples reaching t and v(st) is the feature used in split 
st. When using the Gini index as impurity function, this measure is known as the Gini importance 
or Mean Decrease Gini. However, Equation (6) can be defined for any impurity measure i(t).                           
As mentioned before, a tree is made up of a hierarchy of nodes. A node takes incoming 
observations and sends them to its left or right child node according to a split rule. In so doing, a 
node attempts to purify the incoming dataset. A perfectly pure dataset is one that only contains 
one class of observations. Gini Impurity (7) is a measure of the deviation of a dataset from being 
perfectly pure. 
                                       (7) 
where pi = proportion of class i in the dataset. Decrease in Gini Impurity (8) measures the change 
in impurity at a node caused by sending incoming observations left or right. A high Decrease in 
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Gini Impurity implies that the node and its corresponding feature were useful at separating the 
classes of interest. 
 
                                   (8) 
 
where dincoming = incoming dataset, dL,R = dataset sent left or right, n = number of observations in 
incoming dataset, nL,R = number of observations in left or right dataset, PL = nL /n and PR = nR /n. 
Mean Decrease in Gini Impurity (MDG) averages the change in impurity seen across all nodes that 
used the same feature. This metric measures the forest-wide contribution of the feature at 
separating the different classes and constitutes one measure of feature importance. 
However, FS based on impurity reduction is biased towards preferring features with more 
categories. Secondly, when the dataset has two (or more) correlated features, then any of these 
correlated features can be used as the predictor, with no concrete preference of one over the 
others. But once one of them is used, the importance of others is significantly reduced, since 
effectively the impurity they can remove is already removed by the first feature. As a 
consequence, they will have a lower reported importance. This is not an issue when one wants 
to use FS to reduce data overfitting, since it makes sense to remove features that are mostly 
duplicated by other features. But when interpreting the data, it can lead to the incorrect 
conclusion that one of the features is a strong predictor while the others in the same group are 
non-important, while actually they are very close in terms of their relationship with the 
response variable. The effect of this phenomenon is somewhat reduced thanks to random 
selection of features at each node creation, but in general the effect is not removed 
completely. As regards MDA, the classification results (predicted class vs actual class) of 
observations of the validation set form a tree confusion matrix, from which accuracy is 
calculated. Accuracy, which serves as an unbiased estimate of a tree performance, is used as a 
measure for both determining whether or not to discard a tree, and to calculate MDA. The MDA 
of a feature is the average change in accuracy across the forest, resulting from permuting the 
feature values in observations of the validation set. The classification results from each feature 
permuted observations form a new confusion matrix for each tree. Permuted accuracy for each 
feature is calculated from its corresponding confusion matrix. The change in accuracy (without 
permutation minus with permutation) is then calculated for each feature, for each tree, and 
averaged across the forest. This average (MDA) measures the forest-wide contribution of the 
feature at predicting the different classes. If permutation has no effect on accuracy (i.e. a MDA 
close to 0), one can conclude that the feature is non-important. If that permutation does have 
an effect, the change in accuracy is interpreted as the importance of that feature. Strobl et al. 
[55] compared both MDI and MDA and showed experimentally that the former is biased towards 
some predictor variables. As explained by White and Liu [56], in case of single decision trees this 
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bias stems from an unfair advantage given by the usual impurity functions i(t) towards predictors 
with a large number of values. Strobl et al. [57] later showed that MDA is biased as well, and 
that it overestimates the importance of correlated features. From a theoretical point of view, 
Ishwaran [58] provides a detailed theoretical development of a simplified version of MDA, giving 
key insights for understanding the actual MDA.  
RF are characterized by good accuracy, robustness and ease of use: in general they require very 
little feature engineering and parameter tuning. However, one drawback of this algorithm is the 
difficulty of interpreting the importance ranking of correlated features, in which case strong 
features can end up with low scores and the method can be biased towards features with many 
categories. Thus, it is clear that the importance score alone is not sufficient to identify 
meaningful correlations between features and the decision attribute. Breiman assumed that, 
due to low correlations between individual trees, the importance has normal distribution and 
hence Z-score can be used to assess importance of the variance. Unfortunately, it has been 
shown that Breiman assumption is false and therefore one needs some reference which can help 
to discern the truly important features from the non-important ones.  
Regarding FS, such a process is intended to reduce input data dimension, by solving two 
important problems: facilitate learning accurate classifiers and discover the most interesting 
features, which may provide for better understanding of the problem itself [59]. Regarding the 
first problem, the objective is to learn an optimal classifier using a minimal number of features 
(minimal-optimal problem). Unfortunately, minimal-optimal is in general intractable even 
asymptotically, since there exist data distributions for which every feature subset must be 
tested to guarantee optimality [60]. Therefore it is common to resort to suboptimal methods. 
The second problem is motivated by recent applications in bioinformatics aimed at finding all 
features relevant to the target variable [61]. This defines the all-relevant problem. Thus, there 
are basically two classes of RF-based FS methods: all-relevant FS approaches (e.g. Artificial 
Contrasts with Ensembles (RF-ACE) [62] and Boruta [61]) and minimal-optimal approaches (e.g. 
Recursive Feature Elimination (RFE) and Regularized Random Forest (RRF) [62]). All-relevant FS 
approaches generally select a much larger number of features respect to RFE or RRF. Both the 
RF-ACE and Boruta algorithms are based on the idea first introduced in [63], i.e. the extension 
of the information system with shadows, which are artificial features created by permuting the 
order of values in the original data, and then the use of shadow importance scores to judge the 
score significance obtained by the actual features. However, the algorithms differ in the testing 
scheme used. RF-ACE performs a predefined number of iterations and, at each step, collects the 
importance of real features and the mean importance of all shadows. For each feature, a 
Student’s t-test is applied to check whether its mean importance is significantly larger than the 
mean importance of the shadow attributes and features with p-values less than the chosen 
significance level α are returned as relevant. On the other hand, Boruta checks which features in 
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an iteration achieved higher importance than the best shadow; these events are counted for 
each feature until their number becomes either significantly higher or lower than what is 
expected at random, using a p-value cutoff. If the feature is deemed irrelevant, it is removed 
along with its shadow from the information system. This procedure is repeated until the status 
of all features is decided or until a previously set limit of iterations is exhausted; in the latter 
case, the status of some features may be undecided. Both RF-ACE and Boruta re-shuffle shadow 
features after every iteration. RFE is a group of methods where selection is performed by 
iterative stripping of less important features from the set until the classifier error becomes 
minimal. There are many implementations of this method that differ in the importance source 
used, the stripping criterion and the accuracy assessment method. 
RRF is a modification of a RF that incorporates regularization into the tree growing algorithm 
[64; 65]. Specifically, RRF establishes a penalty for the use of a feature that is not previously 
used in a current tree construction. Such a penalty is proportional to the potential information 
gain from building a split on this feature, so that the selected features are only the ones with 
significant information that is not redundant with respect to already built splits, therefore only a 
subset of all features is actually used in the ensemble.  
 
The Boruta Algorithm 
 
Boruta algorithm, being an all-relevant FS method, tries to find all features carrying information 
usable for prediction, rather than finding a possibly compact subset of features on which some 
classifier has a minimal error. It derives its name from a Slavic spirit of the forest, since the first 
version of Boruta was a wrapper over the RF method. The principle of the algorithm is in line 
with the RF theory, i.e. it copes with problems by adding more randomness to the system: a 
randomized copy of the system is created and merged with the original and a classifier is built 
for this extended system. To assess the importance of a feature in the original system, this 
feature is compared with that of the randomized features. Only features for whose importance 
is higher than that of the randomized features are considered important. Specifically, the 
following procedure is applied: 
 
 an extended system is built, where each feature is replicated. The values of replicated 
features are then randomly permuted across the objects; as a consequence, all 
correlations between the replicated features and the decision feature are random by 
design; 
 several RF runs are performed, the replicated features are randomized before each run, 
and therefore the random part of the system is different for each RF run; 
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 for each run the importance of all features is computed; 
 a feature is deemed important for a single run if its importance is higher than maximal 
importance of all randomized features; 
 a statistical test for all features is performed. The null hypothesis is that importance of 
the feature is equal to the Maximal Importance of the Random Attributes (MIRA). The test 
is a two-sided equality test; the hypothesis may be rejected either when importance of 
the feature is significantly higher or significantly lower than MIRA. For each feature it is 
counted how many times the importance of the feature is higher than MIRA (a hit is 
recorded). The expected number of hits  for N runs is E(N) = 0.5N with standard deviation 
S = N25.0 (binomial distribution with p = q = 0.5). A feature is deemed important 
(accepted) when the number of hits is significantly higher than the expected value and is 
deemed non-important (rejected), when the number of hits is significantly lower than 
the expected value. It is straightforward to compute limits for accepting and rejecting 
features for any number of iterations at a specified confidence level α; 
 features which are deemed non-important are removed from the information system, 
usually with their randomized mirror pair. In some cases the randomized features can be 
kept in the system – it may help in reduction of the number of features deemed 
important, without reducing accuracy of the RF classifier; 
 the procedure is performed for predefined number of iterations or until all features are 
either rejected or conclusively deemed important, whichever comes first. In the former 
case, there are features left, which are neither approved nor rejected, and are further 
referred to as undetermined. 
 
3.1.3 Support Vector Machines 
  
SVM are supervised machine learning models introduced in 1992 by Boser, Guyon, and Vapnik 
[66; 67]. The SVM classifier is widely used in bioinformatics due to its high accuracy, ability to 
deal with high dimensional data, and flexibility in modeling different sources of data [68]. SVM 
belong to the general category of kernel methods [69; 70]. A kernel method is an algorithm that 
depends on the data only through dot-products. The dot product can be replaced by a kernel 
function which computes a dot product in some possibly high dimensional feature space. This 
gives two advantages: first, the ability to generate nonlinear decision boundaries using methods 
designed for linear classifiers; second, the use of kernel functions allows the user to apply a 
classifier to data that have no obvious fixed-dimensional vector space representation. When 
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training a SVM, the practitioner needs to decide how to pre-process the data, what kernel to 
use, and finally, set the parameters of the SVM and the kernel. Specifically, SVM constructs 
a hyperplane or a set of hyperplanes in a high- or infinite-dimensional space, which can be used 
for classification, regression or other tasks; it aims at separating the classes with a decision 
surface that maximizes the distance between the classes (the functional margin), since in 
general the larger the margin the lower the generalization error of the classifier. The surface is 
often called the optimal hyperplane, and the data points closest to the hyperplane are 
called Support Vectors (SV) (Figure 6). Whereas the original problem may be stated in a finite 
dimensional space, it often happens that the sets to discriminate are not linearly separable in 
that space. 
 
Figure 6.  A SVM classification defined by a linear hyperplane that maximizes the separating margins between the 
classes. 
Therefore, the original finite-dimensional space can be mapped into a much higher-dimensional 
space, presumably making the separation easier in that space (Figure 7) [71]. In order to keep 
the computational load reasonable, the mappings used by SVM schemes are designed to ensure 
that dot-products may be computed easily in terms of the variables in the original space, by 
defining them in terms of a kernel function k(xi,xj) selected to suit the problem. Often not only a 
prediction rule is needed but one also wants to identify relevant components of the classifier. 
Thus, it would be useful to combine FS methods with SVM classification, in order to find relevant 
features for prediction. In this context, the objective of FS is three-fold: (i) improving the 
prediction performance of the predictors, (ii) providing faster and more cost-effective 
predictors, (iii) gaining a deeper insight into the underlying processes that generated the data. 
There are three main groups of FS methods: filter, wrapper and embedded methods [72; 73; 74; 
75; 76]. Filter methods simply rank individual features by independently assigning a score to 
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each feature. These methods ignore redundancy and fail in situations where only a combination 
of features is predictive. 
 
Figure 7. From Input Space to Feature Space. 
 
Also, if there is a pre-set limit on the number of features to be chosen (e.g. top 10 features), 
this limit is arbitrary and may not include all informative features. Connecting filtering with a 
prediction procedure, wrapper methods wrap FS around a particular learning algorithm. 
Thereby, prediction performance of a given learning method assesses only the usefulness of 
subsets of features. After a subset with lowest prediction error is estimated, the final model 
with reduced number of features is built [75]. However, wrapper methods have the drawback of 
high computational burden, making them less applicable when the dimensionality increases. 
Wrapper methods also share the arbitrariness of filter methods in FS. The third group of FS 
procedures are embedded methods, which perform FS within learning classifiers to achieve 
better computational efficiency and better performance than wrapper methods. The embedded 
methods are less computationally expensive and less prone to data overfitting than the wrapper 
methods [59]. Among the latter, Guyon [72] proposed the RFE algorithm, which iteratively keeps 
a subset of features that are ranked by their contribution to the classifier. This approach is 
computationally expensive and selecting features based only on their ranks may not derive 
acceptable prediction rules. An alternative to SVM with RFE is to use penalized SVM with 
appropriate penalty functions. The penalty function controls the trade-off between allowing 
training errors and forcing rigid margins and creates a soft margin that permits some 
misclassifications, such as it allows some training points on the wrong side of the hyperplane. 
Increasing the penalty increases the cost of misclassifying points and forces the creation of a 
more accurate model that may not generalize well. Penalized SVM belongs to the group of the 
embedded methods and provides automatic FS. There are several penalization functions such as 
Ridge, LASSO, SCAD, Elastic Net [48; 77; 78] and Elastic SCAD. The Ridge penalty [74] 
corresponds to the ordinary SVM, which does not provide any FS. Since SVM is extremely 
sensitive to the choice of tuning parameters, the search for optimal parameters becomes an 
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essential part of the classification algorithm [79]. More formally, suppose a training dataset with 
input data vector xi Є R
p and corresponding class labels yi Є {-1, 1}, i = 1,...,n is given. The SVM 
finds a maximal margin hyperplane such that it maximizes the distance between classes. A linear 
hyperplane can always perfectly separate n samples in n + 1 dimensions. Assuming that data are 
linearly separable [76], a linear classifier is based on a linear discriminant function: 
                                                           {x : f (x) = wTx + b = 0},                                    (9) 
where w = (w1, w2,..., wp) is the weight vector, i.e. a unique vector of coefficients of the 
hyperplane with ||w||2 = 1, b is the intercept of the hyperplane and the symbol ‘·’ denotes the 
inner product operator. The class assignment for a test data vector xtest Є R
p is given by ytest = 
sign[f(xtest)] (Figure 8). Soft margin SVM allows some data points to be on the wrong side of the 
margin. To account for erroneous decisions, slack variables ξi ≥ 0, i = 1,...,n are defined as the 
distance between a misclassified data point and the corresponding margin. For data points on 
the correct side of the margin ξi = 0, for data points inside the margin 0 < ξi ≤ 1 and for 
misclassified data points ξi > 1. The sum of non-zero ξi is penalized with a cost parameter C and 
then added to the optimization function penalty in the minimization problem:  
 
         s. t. 
          
                                                                 (10) 
The optimization problem (10) is called the soft margin SVM. The cost parameter C is a data 
dependent tuning parameter that controls the balance between minimizing the coefficients of 
the hyperplane and correct classification of the training dataset. C is often chosen by CV. 
Problem (10) can be solved by using convex optimization techniques, i.e. the method of 
Lagrange multipliers [74]. Convex optimization techniques provide a unique solution for 
hyperplane parameters w and b: 
                                           (11) 
 
where αi ≥ 0, i = 1,...,n are Lagrange multipliers. The data points with positive αi, are the SV. All 
data points lying on the correct side of their margin have αi = 0. Thus, they do not have any 
impact on the hyperplane, and Equation (11) can be rewritten as 
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                                 (12) 
where the set of indices of the SV S is determined by S := {i : αi > 0}. The coefficient  can be 
calculated from   for any i with αi > 0. 
 
 
Figure 8. A linear classifier. The hyperplane (line in 2-d) is the classifier decision boundary. A point is classified 
according to which side of the hyperplane it falls on, which is determined by the sign of the discriminant function. 
 
Usually, an average of all solutions for  is used for numerical stability. 
Regarding penalized SVM, Hastie et al. [74] showed that the SVM optimization problem is 
equivalent to a penalization problem which has the ‘loss and penalty’ form 
                                             (13) 
where the loss term is described by a sum of the hinge loss functions l(yi, f (xi)) = [1 - yi f(xi)]+ = 
max(1 - yi f(xi), 0) for each xi, i = 1,...,n. The penalty term is denoted as penλ (w) and can have 
different forms, as mentioned before. 
 
SVM with L2-penalization – Ridge penalty                                
The Ridge penalty uses the L2 norm: 
                       (14) 
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The L2 penalty shrinks the coefficients to control their variance. However, the Ridge penalty 
provides no shrinkage of the coefficients to zero and hence no FS is performed.    
 
 
SVM with L1-penalization – LASSO 
 
The LASSO (‘Least Absolute Shrinkage and Selection Operator’), which resorts to a L1 
penalization function, was originally proposed for generalized linear models by Tibshirani [48]. 
Later, Bradley and Mangasarian [44] adapted the L1-regularisation to SVM. Then, the penalty 
term has the form  
                (15) 
As a result of singularity of the L1 penalty function, L1 -
 SVM can automatically select features by 
shrinking the small coefficients of the hyperplane to zero. By using the L1 norm penalization, the 
number of selected features is bounded by the number of samples and only one feature from a 
group of correlated features is selected, with the elimination of the others.  
 
Smoothly Clipped Absolute Deviation SVM  
 
The SCAD penalty is a non-convex penalty function firstly proposed by Fan [80] and then 
discussed by Fan and Li [81]. Later, Zhang et al. [7878] combined SVM with the SCAD penalty for 
FS. The penalization term for SCAD SVM has the form 
                                             (16) 
where the SCAD penalty function for each coefficient wj is defined as 
                 (17) 
with wj , j = 1,...,p as the coefficients defining the hyperplane and a > 2 and λ > 0 as tuning 
parameters. Fan and Li showed that SCAD prediction is not sensitive to selection of the tuning 
parameter a. Their suggested value a = 3.7 is therefore used as the default value. pSCAD(λ)(w) 
corresponds to a quadratic spline function with knots λ at and aλ. For small coefficients wj, j = 
1,...,p, the SCAD yields the same behaviour as the L1. However, for large coefficients, the SCAD 
applies a constant penalty, in contrast to the L1 penalty, which increases linearly as the 
coefficient increases. The absolute maximum of the SCAD penalty, which is independent from 
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the input data, decreases the possible bias for estimating large coefficient. Furthermore, the 
SCAD penalty holds better theoretical properties than the L1 penalty, as reported in [81]. 
 
Elastic Net  
 
To overcome the limitations of LASSO, Zou and Hastie [77] proposed the Elastic Net, which 
consists in a linear combination of L1 and L2 penalties: 
                        (18) 
The Elastic Net penalty provides automatic FS similar to L1, but is no longer bounded by the 
sample size. Moreover, at the same time this penalty manages the so called grouping effect, i.e. 
the selection of highly correlated features. Increasing λ1 reduces the number of features of the 
classifier, whereas for large λ2 one observes better control of the grouping effect. Wang [82] 
adapted the Elastic Net penalty to SVM classification problems. Therefore, the Elastic Net SVM 
optimization problem can be written as 
                                   (19) 
where λ1, λ2 ≥ 0 are the corresponding tuning parameters. 
 
Elastic Smoothly Clipped Absolute Deviation SVM  
 
Fan and Li [81] showed the advantages of the SCAD penalty over the L1 penalty. However, using 
the SCAD penalty might be too strict in selecting features for non-sparse data. A modification of 
the SCAD penalty analogously to Elastic Net could keep the advantages of the SCAD penalty, 
avoiding at the same time too restrictive sparsity limitations for non-sparse data. Therefore a 
combination of the SCAD and the L2 penalties was proposed by Becker et al. [Errore. L'origine 
riferimento non è stata trovata.], which has the form 
                         (20) 
 
where λ1, λ2 ≥ 0 are the tuning parameters. The Elastic SCAD is expected to improve the SCAD 
method for less sparse data. According to the nature of the SCAD and L2 penalties, the Elastic 
SCAD is expected to show good prediction accuracy for both sparse and non-sparse data. 
The Elastic SCAD combined penalty provides sparsity, continuity, and asymptotic normality when 
the tuning parameter for the Ridge penalty converges to zero, i.e. λ2 → 0. The Elastic SCAD SVM 
optimization problem has the form 
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                             (21) 
 
where λ1, λ2 ≥ 0 are the tuning parameters. 
By solving Equation (21) the same problems as for SCAD SVM turn up, i.e. the hinge loss function 
is not differentiable at zero and the SCAD penalty is not convex in w. The Elastic SCAD SVM 
objective function can be locally approximated by a quadratic function and the minimization 
problem can be solved iteratively similar to the SCAD approach [78; 81]. Renaming the SCAD 
penalty pSCAD(λ1)(|wj|) as pλ1(|wj|), the first-order derivative of the penalty is denoted by p’λ1 
(·). Denote the penalized objective function in Equation (21) by  
 
 For each i (with respect to the fact that yi
2 = 1) the loss term can be split according to 
 
Given an initial value (b0, w0) close to the minimum of A(b, w), the following local quadratic 
approximations is considered: 
 
When wj0 is close to zero, set 
jˆw = 0; otherwise the approximation for the SCAD penalty is used 
 
where |wj| is used instead of wj due to the symmetrical nature of the SCAD penalty. Both 
approximations and their original functions have the same gradient at the point (b0, w0). Thus, 
the solution of the local quadratic function corresponds approximately to the solution of the 
original problem. Minimizing A(b, w) is equivalent to minimizing the quadratic function 
                       (22) 
The solution to Equation (22) satisfies the linear equation system 
                     (23) 
Briefly, the Elastic SCAD SVM can be implemented by the following iterative algorithm: 
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1. set k=1 and specify the initial value (b(1), w(1)) by standard L2 SVM according to Zhang et 
al. [78]; 
2. store the solution of the kth iteration: (b0, w0) = (b
(k), w(k)); 
3. minimize Ã (b, w) by solving Equation (23) and denote the solution as (b(k+1), w(k+1)); 
4. let k = k + 1. Go to step 2 until convergence. If elements w j
(k)
 are close to zero, e.g. 
smaller than 10-4, then the jth variable is considered to be redundant and in the next step 
will be removed from the model. The algorithm stops after convergence of (b(k), w(k)). 
Tuning parameters are used to balance the trade-off between data fit and model complexity and 
they are usually determined by a grid search. The grid search method calculates a target value, 
e.g. the misclassification rate, at each point over a fixed grid of parameter values. This method 
may deal with local minima but it is not very efficient.  The density of the grid plays a critical 
role in finding global optima. For very sparse grids, it is very likely to find local optimal points. 
By increasing the density of the grid, the computation cost increases rapidly with no guaranty of 
finding global optima. The major drawback of the fixed grid approach lies in the systematic 
check of the misclassification rates in each point of the grid, since there is no possibility to skip 
redundant points or to add new ones. When more parameters are included in the model, the 
computation complexity is increased and therefore the fixed grid search is only suitable for 
tuning of very few parameters. On the other hand, an interval search could be used, as 
suggested by Froehlich and Zell, who proposed an efficient algorithm of finding a global 
optimum on the tuning parameter space using a method called EPSGO (Efficient Parameter 
Selection via Global Optimisation) [83]. Using k-fold CV, the dataset is randomly split into k 
disjoint parts of roughly equal size (usually k = 5 or k = 10). In addition, the data is often 
proportionally split, i.e. each fold contains approximately the same distribution of class labels as 
the whole dataset (stratified CV). For each subset, the model is fitted using the other k - 1 parts 
and calculates the prediction error of the selected kth part of the data. The choice of k 
determines a trade-off between bias and variance of the prediction error. Kohavi [84] showed 
that 10-fold stratified CV showed better performance in terms of bias and variance compared to 
10 < k < n. Hastie et al. [74] recommended to perform 5- or 10-fold CV as a good compromise 
between variance and bias. In the proposed pipeline, a 5-fold CV with interval search (default 
setting) for tuning parameters was preferred.  
Generally, L1-SVM, SCAD SVM, Elastic Net SVM and Elastic SCAD SVM outperform ordinary L2-SVM 
using Ridge penalty. From the simulation study in [Errore. L'origine riferimento non è stata 
trovata.] emerged that FS methods with combined penalties are more robust to changes of the 
model complexity than using single penalties alone considering sufficiently large sample sizes. 
The SCAD SVM (followed by the L1-SVM) shows very good performance in terms of prediction 
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accuracy for very sparse models, but fails for less sparse models. Elastic Net and Elastic SCAD, 
which are based on combined penalty functions, show similar performance with respect to 
prediction accuracy and perform well for sparse and less sparse models. Both ‘elastic’ methods 
are able to consider correlation structures in the input data. However, the Elastic SCAD SVM in 
general provides more sparse classifiers than the Elastic Net SVM.  
Moreover, SVM can be adapted to become a nonlinear classifier through the use of nonlinear 
kernels. While SVM is a binary classifier in its simplest form, it can function as a multiclass 
classifier by combining several binary SVM classifiers, i.e. creating a binary classifier for each 
possible pair of classes.  
 
 
3.2 Second step: classifier development 
 
In the second step of the proposed pipeline, several Linear SVM models [85] are implemented by 
varying SVM parameters and the number of included features on the basis of forward selection 
along the bootstrap generated list of the first step. To adjust for overoptimism, each model is 
validated with a LOOCV procedure [86] (see paragraph 3.2.2), using the Youden index [87] as 
measure of classification performance. The choice of the final model is based both on 
maximizing classification performance and minimizing the number of features included in the 
classifier (parsimony criterion). 
The development of a classifier using high dimensional data is particularly challenging because 
firstly implies the choice between a classical (e.g. Penalized Logistic Regression model) or a 
machine learning algorithm (e.g. SVM models). In our pipeline, the well-known Linear SVM model 
was preferred to other more complex SVM models, since it is a simple model requiring the tuning 
of only two parameters: 
 
1) the cost parameter, which controls the penalty imposed to the SVM model in case of 
misclassification of a training subject and therefore model complexity (the higher the cost, the 
less the misclassified subjects); 
 
2) the class weights, indicating the influence assigned to the two classes (it should be used a 
fortiori in case of unbalanced groups of samples). 
 
However, different kernel functions may be used for nonlinear SVM: the ‘custom’ ones (i.e. 
already implemented in R software) such as polynomial, Sigmoid, Gaussian Radial Basis Function 
(RBF) or user-defined kernels. The model choice and the selection of the ‘proper’ kernel 
function represent two issues to be further investigated. For the implementation of the Linear 
SVM model, the svm function included in the e1071 package is used. The SVM output, 
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represented by the ‘scores’ (also indicated as ‘decisional values’), is transformed into 
probability estimates by means of the Platt’s scaling [88], a method invented by John Platt in 
the context of SVM, but that can be also applied to other classification models: a binary logistic 
regression is applied (fitted within a k-fold CV procedure), where the dependent variable is the 
class and the independent variable is the SVM score. This scaling produces two prediction errors, 
i.e. by the SVM model and by the logistic model. The CV involved in Platt’s scaling is an 
expensive operation for large datasets and the choice of k is another issue to be further 
explored, but conventionally the 5-fold CV is used. In addition, the probability estimates may be 
inconsistent with the scores, in the sense that the ‘argmax’ of the scores may not be the 
‘argmax’ of the probabilities (e.g. in binary classification, a sample may be labeled by predict as 
belonging to a class that has probability < 0.5 according to predict probabilities). To conclude, 
the above probability estimates cannot be considered ‘true’ class probabilities (such as, for 
example, those directly estimated by using a binary logistic model), rather being ‘surrogated’ 
class probabilities. Therefore, it would be advisable not to transform the SVM scores into the 
class probabilities. 
 
3.2.1 Linear Support Vector Machines 
 
Linear SVM assumes that data are linearly separable. For a two-class classification problem on a 
dataset S = {xi; yi}i=1
n, where xi Є R
p is the feature vector of the ith data point, and yi Є {-1; 1} is 
the corresponding label, the linear SVM classifier recovers an optimal separating hyperplane 
wTx+b = 0 which maximizes the margin of the classifier. This can be formulated into the 
following constrained optimization problem [89; 90]: 
                                       (24) 
where l{w;xi, yi} = [1 - yf(x)]+  = max (1 − yf(x), 0) is the hinge loss, f(x) = w
Txi - γ  is the decision 
function, w is the weight vector, γ is the bias term. SVM can also be trained by solving the 
Lagrangian dual of Equation (24), which results: 
                
                      (25) 
The classifier for linear SVM is then represented by 
                               (26) 
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                                      (27) 
The weight vector can be computed explicitly by  
 
and used for prediction. The advantage of solving the dual form is that only dot-products 
between data-points are needed. Consequently, the nonlinear SVM can then be trained by 
replacing the dot-products in Equation (25) with the corresponding kernel K(xi,xj). The resulting 
classifier for the nonlinear SVM is then represented by 
                                            (28)  
where the α’s are the Lagrangian multipliers. Conceptually, the only difference between the 
nonlinear SVM and their linear counterparts is in the use of kernel function instead of the dot-
product in Equation (27). Computationally, linear SVM can be directly evaluated by using 
Equation (26), which is much more efficient than nonlinear SVM for prediction purposes. Note 
that only those instances with positive value of αi, i.e. the SV, will contribute to classification. 
As mentioned before (paragraph 3.1.3), different kernels can be used for nonlinear SVM.   
The linear kernel is a special case of a degree-d polynomial kernel (d=1) 
 
where  c ≥ 0 is a free parameter trading off the influence of higher-order versus lower-order 
terms in the polynomial. When c = 0, the kernel is called homogeneous.     
The Gaussian RBF kernel is the most widely used for nonlinear SVM 
 
where γ > 0 is the scale parameter that controls the width of Gaussian, i.e. the decay rate of 
the distance. The parameter γ plays a similar role as the degree of the polynomial kernel in 
controlling the flexibility of the resulting classifier.        
The Hyperbolic Tangent kernel, also known as the Sigmoid kernel, has the form 
 
where there are two adjustable parameters, the slope α and the intercept constant c. A common 
value for α is 1/N, where N is the data dimension.  
Despite the effectiveness in classification of nonlinear data, the nonlinear SVM has much higher 
computational complexity for prediction than its linear counterpart. According to Equation (28), 
it requires |V|d summations and |V| exponential operations to compute the kernel function 
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values for evaluating the classifier output at a single testing instance, where d is the data 
dimension and |V| is the cardinality of the set of SV. Prediction can be very time consuming, 
depending on the training data set size and the degree of nonlinearity. To cope with a highly 
nonlinear decision boundary, a great number of SV may be generated in the training process, 
which leads to higher computational complexity in testing time. Also, a larger training dataset 
will result in greater number of SV in training than a smaller dataset does. This also adds up to 
the complexity of prediction. Hence nonlinear SVM is inefficient for large-scale prediction tasks 
where there are thousands or millions of data points to classify in the validation set. Linear SVM, 
on the other hand, do not have such problem. It can perform prediction with d summations via 
Equation (26) and the testing time is independent of the number of SV. This makes it a much 
more efficient alternative than nonlinear SVM. Moreover, there are very efficient algorithms for 
training linear SVM which can run in linear time ([91]; [92]). This is impossible for nonlinear SVM, 
as the evaluation of the full kernel matrix is already quadratic in time complexity. Nevertheless, 
the performance of linear SVM is usually suboptimal as compared to nonlinear ones since they 
cannot handle linearly inseparable data. It would be desirable to develop an SVM model with 
both the efficiency of the linear SVM at the prediction stage and the classification accuracy of 
the nonlinear SVM classifier [93]. 
3.2.2 Cross Validation procedure 
In data mining, a typical task is to learn a model from available data. The problem with 
evaluating such a model is that the classification rule developed from the dataset of known 
data on which training is run (training dataset) might fail in predicting unseen data (validation 
dataset). CV, sometimes called rotation estimation ([94]; [95]; [96]),  is a procedure for 
estimating the generalization performance in this context. The idea for CV originated in the 
1930s [97]. Mosteller et al. [98] developed the idea. A clear statement of CV, which is similar to 
current version of k-fold CV, first appeared in [99]. In 1970s, both Stone [86] and Geisser [100] 
employed CV as means for choosing proper model parameters, as opposed to using CV purely for 
estimating model performance. Currently, CV is widely accepted in data mining and machine 
learning community, and serves as a standard procedure for performance estimation and model 
selection. There are two possible goals in CV:  
 to estimate performance of the learned model from available data using one algorithm, 
i.e. to gauge the generalizability of an algorithm;  
 to compare the performance of two or more different algorithms and find out the best 
algorithm for the available data, or alternatively to compare the performance of two or more 
variants of a parameterized model.  
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The above two goals are highly related, since the second goal is automatically achieved if one 
knows the accurate estimates of performance. One of the main reasons for using CV instead of 
using the conventional validation (e.g. partitioning the dataset into two sets of 70% for training 
and 30% for validation) is that the error (e.g. Root Mean Square Error) on the training set in the 
conventional validation is not a useful estimator of model performance and thus the error on the 
validation data set does not properly represent the assessment of model performance. This may 
be because there is not enough data available or there is not a good distribution and spread of 
data to partition it into separate training and validation sets. In these cases, a fair way to 
properly estimate model prediction performance is to use CV as a powerful general technique 
[101]. Indeed, CV combines (averages) measures of fit (prediction error) to correct for the 
optimistic nature of training error and derive a more accurate estimate of model prediction 
performance. 
Various procedures of CV have been proposed, such as resubstitution validation, Hold-Out 
Validation (HOV), k-fold CV, LOOCV and repeated k-fold CV. 
 
Resubstitution validation 
 
In resubstitution validation, the model is learned from all the available data and then tested on 
the same set of data. This validation process uses all the available data but suffers seriously 
from data overfitting. Therefore, the algorithm might perform well on the available data yet 
poorly on future unseen data.  
Hold-Out Validation  
To avoid data overfitting, an independent validation set is preferred. A natural approach is to 
split the available data into two parts: one for training and the other for validation. The 
validation data is held out and not looked at during training. HOV avoids the overlap between 
training data and validation data, yielding a more accurate estimate for the generalization 
performance of the algorithm. One drawback is that this procedure does not use all the available 
data and the results are highly dependent on the choice for the training/validation split. The 
instances chosen for inclusion in the validation set may be too easy or too difficult to classify 
and this can skew the results. This issue can be partially addressed by repeating HOV multiple 
times and averaging the results, but unless this repetition is performed in a systematic manner, 
some data may be included in the validation set multiple times while others are not included at 
all, or conversely some data may always fall in the validation set and never get a chance to 
contribute to the learning phase. Therefore, k-fold CV is used to deal with these challenges and 
fully utilize the available data.  
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K-fold Cross Validation  
 
In k-fold CV the data is first partitioned into k equally (or nearly equally) sized segments or 
folds. Subsequently k iterations of training and validation are performed such that within each 
iteration a different fold of the data is hold-out for validation while the remaining k - 1 folds are 
used for learning. Data is commonly stratified prior to being split into k folds. Stratification is 
the process of re-arranging the data as to ensure that each fold is a good representative of the 
whole.  
Leave-One-Out Cross Validation 
 
LOOCV is a special case of k-fold CV where k equals the number of instances in the data (i.e. k = 
n). In other words in each iteration nearly all the data except for a single observation are used 
for training and the model is tested on that single observation. An accuracy estimate obtained 
using LOOCV is known to be almost unbiased but it has high variance, leading to unreliable 
estimates [102102]. It is still widely used when the available data are very rare, especially in 
bioinformatics where only dozens of data samples are available.  
Repeated k-Fold Cross-Validation  
 
Large number of estimates are always preferred in order to obtain reliable performance 
estimation. In k-fold CV, only k estimates are obtained. A commonly used method to increase 
the number of estimates is to run k-fold CV multiple times. The data is re-shuffled and re-
stratified before each round. 
 
In the proposed pipeline, which was applied in the context of bioinformatics, the LOOCV was 
used, since very often these types of data are characterized by a small amount of samples. 
 
3.3 Presentation of results 
 
A good presentation of results should be immediate and easy to understand. To this aim, 
innovative plots are proposed to graphically summarize the results obtained in each step of the 
procedure used for class prediction. 
3.3.1 The ‘egg-shaped’ plot 
An example of the egg-shaped plot representation of top ranking features is shown in Figure 9.  
The nodes and edges represent, respectively, feature bootstrap occurrences and co-occurrences 
(pairwise occurrences). The larger the node, the more often the corresponding feature occurs; 
the thicker the edge between two features, the more often they are selected together in 
bootstrap samples. The plot can be filtered to show features with co-occurrences in the 
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bootstrap samples at least equal to a certain threshold. We report here an example of ‘egg-
shaped’ plot, where the feature miR-451 emerges as the most important feature, followed by 
miR-16, miR-486-5p, miR-92a and miR-22. The most selected features are also the most 
interconnected: the strongest co-occurrence involves miR-451 connected to miR-16, followed by 
miR-486-5p and miR-92a. Also miR-16 presents several interconnections with miR-92a, miR-486-
5p, and miR-22.  
 
Figure 9. Example of egg-shaped plot of the class prediction results (first step). 
3.3.2 The ‘ROC space’ plot 
The LOOCV SVM performances can be graphically summarized in terms of False Positive Rate 
(FPR) and True Positive Rate (TPR) by implementing a ‘ROC space’ plot, which can be seen as a 
generalization of the ROC curve (an example is shown in Figure 10). The best performing groups 
of models are those nearest to the point (FPR=0, TPR=1) of the ‘ROC space’. 
 
Figure 10. Example of ROC space plot of the class prediction results (second step). The best performing groups 
of linear SVM models are indicated by an ID number outside the circles; inside each circle is reported the 
number of models produced by the LOOCV procedure corresponding to a specific classification performance. 
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3.4 The Cineca system 
 
Cineca is a non-profit consortium, made up of 70 Italian universities, four national research 
centres, and the Ministry of Universities and Research (MIUR), established in 1969 in Casalecchio 
di Reno, Bologna. In 2013 it was the most powerful supercomputing centre for scientific research 
in Italy, ranked at the 23rd position in 2014 and at the 32nd position in 2015 [103]. The 
institutional mission of the consortium is to support the Italian scientific community 
through supercomputing and scientific visualization tools. Since the end of the 1980s, Cineca has 
broadened the scope of its mission by embracing other IT sectors, developing management and 
administrative services for universities and designing ICT systems for the exchange of 
information between the  Ministry of Education, MIUR and the Italian national academic system. 
The consortium is also strongly committed to transfer technology to many categories of users, 
from public administration to the private enterprises. Moreover, Cineca takes part in several 
research projects funded by the European Union for the promotion and development of IT 
technologies (grid computing, bioinformatics, digital content, the promotion of transnational 
access to European supercomputing centres, etc.). Cineca can be seen as a high technology 
bridge between the academic world, research and the world of industry and public 
administration.  
The Cineca system was used to take advantage of its powerful hardware in order to perform 
computationally intensive analyses, involved in the implementation of the Elastic Smoothly 
Clipped Absolute Deviation SVM (Elastic SCAD SVM) or, alternatively, the SVM with L1-
penalization (L1-SVM) algorithms. 
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4. A comprehensive pipeline for class comparison and 
class prediction  
 
Taking into account the results of the simulation study on two-sample tests for class comparison 
and the methodological insights on the classification algorithms for class prediction, a 
comprehensive pipeline for class comparison and class prediction (Figure 11) was developed 
with innovative applications of existing bioinformatics methods including: 
 
1) the combination of the results of two statistical tests (t and AD) to detect features with 
significant fold change or general distributional differences in class comparison; 
 
2) the application of a bootstrap selection approach together with machine learning 
techniques included in a Leave-One-Out Cross Validation (LOOCV) procedure to guarantee 
result generalizability and study the interconnections among the selected features in class 
prediction.  
 
Figure 11. Workflow for class comparison and class prediction analyses. 
 
The presented pipeline may be extended to other kinds of 'omics' studies by introducing proper 
methodological adjustments. For instance, with small sample sizes, the Wilcoxon-Mann-Whitney 
test should be used for class comparison analysis; for class prediction analysis, with non-coding 
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RNA Sequencing data, which are count variables, models suitable for analyzing count data should 
be used (i.e. Negative Binomial, Poisson distribution based models). 
 
5. Real data applications  
 
We applied the proposed pipeline to two different high dimensional datasets, i.e. plasmatic 
miRNA data [10] and SESI-MS data [104]. 
 
5.1 Plasmatic microRNA data 
 
Proposal of supervised data analysis strategy of plasma miRNAs from 
hybridisation array data with an application to assess hemolysis-
related deregulation 
 
Abstract 
Background: Plasma miRNAs have the potential as cancer biomarkers but no consolidated 
guidelines for data mining in this field are available. The purpose of the study was to apply a 
supervised data analysis strategy in a context where prior knowledge is available, i.e. that of 
hemolysis-related miRNAs deregulation, so as to compare our results with existing evidence. 
Results: We developed a structured strategy with innovative applications of existing 
bioinformatics methods for supervised analyses including: 1) the combination of two statistical 
(t- and Anderson-Darling) test results to detect miRNAs with significant fold change or general 
distributional differences in class comparison, which could reveal hidden differential biological 
processes worth to be considered for building predictive tools; 2) a bootstrap selection 
procedure together with machine learning techniques in class prediction to guarantee the 
transferability of results and explore the interconnections among the selected miRNAs, which is 
important for highlighting their inherent biological dependences. The strategy was applied to 
develop a classifier for discriminating between hemolyzed and not hemolyzed plasma samples, 
defined according to a recently published hemolysis score. We identified five miRNAs with 
increased expression in hemolyzed plasma samples (miR-486-5p, miR-92a, miR-451, miR-16, miR-
22).  
Conclusions: We identified four miRNAs previously reported in the literature as hemolysis 
related together with a new one (miR-22), which needs further investigations. Our findings 
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confirm the validity of the proposed strategy and, in parallel, the hemolysis score capability to 
be used as pre-analytic hemolysis detector.  
 
Background 
MicroRNAs (miRNAs) are highly conserved single-stranded small RNA molecules (~19-22 
nucleotides long) that play a key role in post-transcriptional gene regulation. To date, more than 
2600 human miRNAs have been identified (miRBase V21 [1]). This class of small RNAs is being 
widely studied in oncology and a functional implication in cancer development and progression 
has been demonstrated [2,3,4]. Recent studies have shown that miRNAs can be released from 
cells (encapsulated in exosomes and/or bound to proteins and lipoproteins) and enter into the 
circulation as a consequence of an active release or apoptotic and necrotic cell death [5,6,7,8]. 
As a result of miRNA release from cells, these molecules have also been found in every human 
body fluid, in a stable form protected from endogenous RNases, thus making plasma miRNA 
levels well suited for non invasive analysis in patient samples [9,10]. Independent studies have 
reported the feasibility of using plasma miRNAs as promising disease biomarkers and, in the 
context of malignancies, they have shown a potential as molecular tools for detection, prognosis 
and treatment decision making of various cancers [11,12]. However, some biological or technical 
challenges could limit the development of this class of biomarkers [13,14], thus probably giving 
an explanation of the poor concordance among inter-study results [15].  
In the attempt to develop a multimarker classifier using plasma miRNA data, some issues arising 
during the discovery process challenge the researchers. Moreover, so far there are no 
consolidated guidelines for data analysis in this context. This prompted us to develop a 
structured strategy for supervised analyses with the aim of: (1) in class comparison analysis, 
detecting differences of miRNA distributions between the two compared classes; (2) in class 
prediction analysis, discovering the top discriminating features, study their associations and 
interconnections, and developing a 'robust' cross validated classifier. In the class comparison 
step we proposed the combined use of two tests: the t-test and the nonparametric Anderson-
Darling (AD) test [16]. The former is commonly applied for class comparison being directly 
related to the fold change (FC), which is taken as a measure of the 'differential expression' 
direction and strength; however, the FC is limited to the exploration of differences between the 
mean expression values in the two compared classes. On the other hand, the AD test is able to 
detect more general differences between two classes, which could reveal hidden differential 
biological processes. In class prediction we set up an assumption-free procedure for the 
development of a cross validated classifier, after a robust miRNA ordering via bootstrap 
sampling.  
The above approaches were applied to plasma miRNAs determined on a subset of patient 
samples from a clinical trial series [17]. RNA extracted from these samples was subjected to 
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Agilent miRNA hybridization array. A microarray approach was chosen because it allows reaching 
a higher throughput than PCR-based assays (even if it is able to analyze only miRNAs already 
known and annotated in miRBase [18]) and is expected to be advantageous in a discovery phase. 
Different miRNA microarray platforms, able to measure circulating miRNAs, are commercially 
available, including GeneChip miRNA Array by Affimetrix, Human miRNA Microarray by Agilent. 
Among these, we opted for the Agilent system, since it emerged as one of those obtaining the 
highest performances and is probably the most commonly used. In addition, in a pilot study that 
we have recently published, the feasibility of using such a platform in miRNA detection also from 
archival plasma samples was evaluated [19] and we found a very high correlation between 
technical replicates and a good correlation between different batches. We focused on the 
comparison between miRNA expression profiles from hemolyzed and not-hemolyzed plasma 
samples,  thus choosing a context where prior knowledge on deregulated miRNAs is available.   
 
Methods 
The strategy that we developed for data preparation and data analysis is illustrated in Additional 
Figure 1. All analyses were performed using R and in particular Bioconductor libraries [20]. The 
details are reported below. 
 
Study design  
Plasma samples included in the present study come from patients entering a randomized breast 
cancer prevention Trial [17]. In details, we analyzed a subset of patients from the group of 1476 
patients enrolled in the control (not treated) arm of the trial at the Fondazione IRCCS Istituto 
Nazionale dei Tumori. Blood samples, collected using heparin, were separated into plasma 
aliquots by centrifugation (2000xg; 15 min at 4°C) and stored at −80°C until assayed; no thawing 
accident occurred during storage. Since the blood samples were collected for different purposes, 
no information are available on erythrocyte or platelet counts. Nevertheless, the presence of 
hemolysis was evaluated in the plasma samples on the basis of the 'Hemolysis Score’ (HS) 
previously published by our group [21]. Our 'controls' were not-hemolyzed plasma samples (HS ≤ 
0.057) and our 'cases' were the samples with HS > 0.14, roughly corresponding to a visible 
hemolysis. The remaining samples showing 0.057 < HS ≤ 0.14 were not analyzed. As cases and 
controls could be unbalanced for some variables, a matching procedure was used, by applying 
the nearest neighbor matching within specified propensity score (PS) calipers [22] in order to 
have a more relaxed criterion which would enable us to match all the hemolyzed samples. Given 
the PS, that is the probability of assignment to one group conditional on some characteristics of 
patients and samples (i.e. disease status, age at drawing and drawing year), we matched each 
case with two controls with the closest PS within the specified range (the caliper width). We 
used the recommended caliper width, which is equal to the 20% of the standard deviation of the 
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PS logit [23]. After matching we randomly split the sample in half into a training set for 
supervised analyses and a validation set for internal validation of results, maintaining the 1:2 
ratio between cases and controls. 
Sample processing  
Plasma isolation and RNA extraction were carried out as previously described [19]. Briefly, 
total RNA was extracted from 350 μl plasma collected in heparin using the commercial column-
based system Qiagen miRNeasy R Mini Kit (Qiagen, Valencia, CA, USA), slightly modified. 
Briefly, 400 μl of plasma/medium were thawed on ice and centrifuged at 1000×g for 5 min in a 
4 °C microcentrifuge. An aliquot of 350 μl of plasma per sample was transferred into a new 
microcentrifuge tube and 1300 μl of a Qiazol mixture containing 1.25 μg/ml of MS2 
bacteriophage RNA (Roche Applied Science, Milan, Italy) and a RNA spike-in (ath-miR-159a) to 
be able to eventually test the recovery efficiency by RT-PCR anlysis. A rinse step (500 μl 
Qiagen RPE buffer) was repeated 3 times. Total RNA was eluted by adding 25 μl of RNase-free 
water to the membrane of the spin column and incubating for 1 min before centrifugation at 
15,000×g for 1 min at room temperature.  The heparin contained in the RNA samples was 
digested using heparinaseI (Sigma- Aldrich, St. Louis, MO, USA), in the presence of an RNase 
inhibitor, (RNAsin; Promega, Madison, WI, USA) for 1 hour at room temperature, and RNA was 
stored at -80°C. The heparinease digestion was performed to make RNA suitable for 
downstream RT-PCR analysis (not pertinent to this paper, manuscript in preparation). In fact, 
For many years, the use of heparin for blood collection has been avoided in case of subsequent 
RNA extraction, since the anticoagulant inhibits PCR amplification [24, 25, 26, 27]. However, 
we have recently demonstrated that if adequately treated with heparinase, plasma samples 
derived from blood collected with heparin tubes are suitable for miRNA expression analysis, 
without affecting miRNA detection [28]. Hybridization on Agilent Human miRNA microarrays 
was carried out by Functional Genomics facility according to the manufacturer's instructions as 
previously described [19]. Briey, SurePrint G3 Human v16 miRNA 8x60K microarrays (G4870A) 
designed on miRBase 16.0 from Agilent Technologies were used. 2.5 μl of total RNA was 
dephosphorylated at 37°C for 30 min with calf intestinal phosphatase and denatured using 100% 
DMSO at 100°C for 5 min. Samples were labeled with pCp-Cy3 using T4 ligase by incubation at 
16°C for 1 hour and hybridized. Arrays were washed according to manufacturer's instructions 
and scanned at a resolution of 5 μm using an Agilent 4000B scanner. Data were acquired using 
Agilent Feature Extraction software version 10.7. 
 
Data pre-processing 
Raw data were summarized as previously described [19]. Briefly, in the employed platform, 
each miRNA is targeted by one to four different probes and each probes spotted 10 to 40 times 
on the array. Then, the total signal for each miRNA was obtained by summing the probe signals 
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derived from Agilent Feature Extraction software. Using this software, each probe is defined 
detected if its value is greater than three times its standard error, and each miRNA is defined 
as detected if at least one of the probes is detected. Summarized data were log2 transformed. 
Only the 1205 human ('hsa') miRNAs were considered in subsequent analyses. Microarray data 
are MIAME compliant and were deposited into the NCBI's Gene Expression Omnibus (GEO) 
database with accession number 'GSE59993' [29]. MiRNAs were filtered at 90%, i.e. we retained 
only miRNAs detected in at least 90% of all samples. By applying a less stringent filtering (i.e. 
10% filtering), no additional differentially expressed (DE) miRNAs could be identified (data not 
shown), as compared with those obtained with the 90% filtering. 
As regard to the normalization step, we applied the ratio-based approach [30] that is like 
using, in turn, all miRNAs as normalizers but eliminating any duplications, i.e. each miRNA pair 
only appeared once. 
 
Supervised data analyses 
We implemented supervised approaches for class comparison and class prediction on the 
training set samples using both raw (not normalized) and ratio-normalized data. Class 
comparison analysis, aimed at identifying features (miRNAs or miRNA ratios) DE between cases 
and controls, was based on the combined use of the t- and the non parametric AD [16] tests. 
While the t-test considers only location differences, the AD test is an 'omnibus test' [31], i.e. it 
considers the whole feature distribution, granting more importance to the observations in the 
tails. The latter characteristic becomes valuable when one is interested in finding signals that 
are only present in patient subsets diverging from the center of the distribution. 
Moreover, plasma miRNA data, like other 'omics' data, have often not normal distributions and 
the sample sizes are often small. In presence of distributions with asymmetries, multimodality 
or heavy tails, the AD test reveals useful for the identification of interesting features. We 
considered the asymptotic version of the AD test, with correction for the presence of ties. The 
Benjamini-Hochberg method was used to distinctly adjust t- and AD p-values in order to control 
for the False Discovery Rate (FDR) [32]. In particular, we combined the results of the two tests 
by considering as significantly DE the features for which the FDR-adjusted p-value was below 
the 5% level for at least one of the two tests. This procedure could inflate the overall Type I 
error; however, we expect such an effect to be marginal because the two tests statistics are 
likely to be dependent and, in addition, both tests are applied to the same data. 
For class prediction analysis, aimed at developing a classifier able to accurately discriminate 
between hemolyzed and not-hemolyzed samples, a two-step procedure was set up: firstly, with 
the purpose of obtaining a robust ranking of features with distributional differences between 
the two classes, a 'bootstrap selection' was performed, according to the strategy proposed by 
Austin and Tu [33]. We extracted 1000 bootstrap samples [34] and we applied three machine 
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learning selection algorithms, i.e. Prediction Analysis for Microarrays (PAM) [35], Random 
Forests (RF) with Boruta feature selection method [36] and Elastic Smoothly Clipped Absolute 
Deviation (SCAD) Support Vector Machines (SVM) [37], while maintaining the same proportion of 
hemolyzed and not-hemolyzed in each group. The three methods were chosen because they 
overcome the 'curse of dimensionality' usually present in high-dimensional data (i.e. more 
features than subjects) and because they are conceptually different algorithms that we 
considered as 'representative' of methodological categories using different decision rules for 
classification (i.e. a nearest centroid, a decision tree and a SVM based method, respectively). 
PAM, being characterized by a minor complexity respect to the other two algorithms, may be 
insufficient to appreciate complex classification patterns. Among the other two more 
sophisticated methods, RF overcome the main disadvantage of decision trees methods, which is 
their tendency to data overfitting and, like PAM, are fast and nonparametric, so one has not to 
worry about outliers. On the other hand, RF only output measures of feature importance, the 
interpretation of which is controversial with correlated features [38]. The inherent biological 
dependence among the features, which implies correlation among miRNAs, was taken into 
account by using the Elastic SCAD SVM algorithm. The features were ranked on the basis of the 
frequency of simultaneous selection by the three above algorithms, discarding the features not 
selected in at least one bootstrap sample. None of the three algorithms is uniformly superior in 
detecting class differences. Our strategy seeks to overcome the above limitation by implicitly 
relying on an intersection criterion, by which a feature emerges as ’strong’ regardless of the 
statistical technique used for analysis. As second step, aimed at developing a cross validated 
classifier, we implemented a linear SVM model [39], using the features previously ranked 
according to the bootstrap selection. We chose the linear SVM since it is a simple model 
requiring only the tuning of two parameters, i.e. the cost, which controls model complexity 
and the class weights, indicating the influence assigned to the two classes. Different models 
were fitted by varying the number of included features, forwardly selected according to the 
bootstrap generated list. The models were then cross validated with a leave-one-out cross 
validation procedure [40] to adjust for overoptimism the classification performance measures, 
i.e. sensitivity, specificity and Youden index [41]. The final model used for developing the 
classifier was chosen according to both the criteria: best classification performance, measured 
by the highest Youden index, and smallest number of features included in the model. Finally, 
the classification performance measures of the chosen models were calculated on the 
validation set, together with their corresponding bootstrap 95% confidence intervals (CI) taken 
as an estimate of the performance measure variability. 
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Results and discussion 
Sample processing and data pre-processing 
After case-control matching, 78 samples were selected, 26 hemolyzed and 52 not-hemolyzed; 39 
samples (13 hemolyzed vs 26 not-hemolyzed) were included in the training and validation set, 
respectively. After the filtering performed on the training set, 88 miRNAs were retained, based 
on which a total of 3828 ratios were generated.  
Class comparison 
The results of class comparison using raw and ratio data with the lists of miRNAs significantly 
DE according to t- or AD test, after adjusting for multiple testing were graphically summarized 
via volcano and concordance plots (Additional Figure 2). Concerning raw data, four miRNAs 
(4.5%) were significant at the t- or AD test. Three miRNAs (miR-486-5p, miR-92a, miR-451) 
were identified as up-regulated in hemolyzed samples through the t-test (Additional Figure 
2A), being also detected by the AD test, as shown in the second quadrant of the concordance 
plot in the Additional Figure 2B (the adjusted p-values were coincident). Moreover, one more 
miRNA (miR-16) was significant according to the AD test alone (Additional Figure 2B), although 
the t-test p-value was near to the significance threshold. Regarding ratio data, 224 miRNA 
ratios (5.8%) were significant at the t- or AD test. We detected 104 ratios as significantly up-
regulated and 94 ratios as significantly down-regulated with the t-test, for a total of 198 ratios, 
which involved 80 miRNAs (Additional Figure 2C). One hundred and seventy ratios (involving 68 
miRNAs, including the four previously selected with raw data) were detected by both tests 
(first quadrant of Additional Figure 2D), 28 ratios (involving 27 miRNAs) only by the t-test 
(second quadrant of Additional Figure 2D) and 26 ratios (involving 29 miRNAs) only by the AD 
test (fourth quadrant of Additional Figure 2D). The features significantly DE in the training set 
at the raw and ratio data analysis were also evaluated in the validation set. All the 4 miRNAs 
and 203 over 224 ratios resulted DE in the validation set for the t- or the AD test (Additional 
Table 2). 
 
Class prediction 
Figure 1 summarizes the results of the first step of class prediction analysis with raw data 
('bootstrap selection'). In particular, in Figure 1A the miRNAs are ranked according to the 
number N of occurrences in the bootstrap samples, i.e. the number of times in which they are 
jointly selected by the three machine learning algorithms. miRNAs identified in class 
comparison analysis as significantly up-regulated in hemolyzed samples resulted at the top 
positions of bootstrap ranking (top 35 miRNAs in Figure 1A). MiR-451 headed clearly in class 
prediction, being selected in 846 out of 1000 bootstrap samples, followed by miR-16 
(779/1000), miR-486-5p (734/1000), miR-92a (668/1000) and miR-22 (448/1000). An egg-
55 
 
shaped plot representation of top ranking miRNAs is shown in Figure 1B, where node size and 
edge thickness are proportional to the frequency of miRNAs occurrences and co-occurrences 
(pairwise occurrences) in the bootstrap samples; a filtering was applied to show only those 
miRNAs with co-occurrences at least equal to 300. The most frequent co-occurrences are 
shown in Figure 1C. Generally, the most selected miRNAs were also the most interconnected. 
In fact, considering miR-451, the strongest co-occurrence involved miR-16, being the two 
miRNAs jointly selected in 711 out of 1000 bootstrap samples, followed by miR-486-5p (624 co-
occurrences) and miR-92a (606 co-occurrences). Also miR-16 presented several 
interconnections with miR-92a (604 co-occurrences), miR-486-5p (587 co-occurrences), and 
miR-22 (411 co-occurrences). MiR-451, miR-16, miR-486-5p and miR-92a have been previously 
reported in the literature as hemolysis-related plasma miRNAs [20], while miR-22 was selected 
in a high number of bootstrap samples and linked to the top four miRNAs. Ratio data generally 
led to smaller bootstrap occurrences, since each miRNA appeared in several ratios. However, 
miR-486-5p, miR-92a, miR-451 and miR-16 were included in the top eight ratios, with 
occurrences equal to 357 (1st position), 304 (2nd position), 270 (4th position) and 214 (8th 
position), respectively. MiR-22 appeared at the 31st position, with 121 occurrences. The 
'autoselected' specific normalizers were miR-4257 for miR-486-5p and miR-92a, and miR-4286 
for miR-451 and miR-16. The top co-occurrence involved miR-92a/miR-4257 and miR-486-
5p/miR-4257, with a frequency equal to 200. 
As regard to the classifier development (step 2), the 'ROC space' plot in Figure 2 summarizes 
the SVM model performance in terms of false positive rate (FPR) and true positive rate (TPR); 
as true for the ROC curves, ideal models are those closest to the point (0,1), corresponding to 
100% sensitivity and specificity. The numbers inside the circles count the models with a specific 
combination of FPR and TPR, while the numbers outside (ID) rank each group of models in 
terms of performance, as quantified by the Youden index (e.g., ID=1 indicates the group of 
models with the highest Youden index). Considering raw data (Figure 2A), we identified 8 best 
performing groups; among them, 16 models (ID=1) showed the highest Youden index equal to 
0.81. Using ratio data (Figure 2B) only one model stood alone in leading the rank classification 
list, with a Youden index of 0.73. 
The above results are numerically shown in Table 1 (left panel) only for the best performing 
groups, i.e. those ID numbered in the Figure 2; additionally, for the specific model chosen in 
each group according to a parsimony criterion (smallest number of features), we show the 
parameters (middle panel) and the performance evaluated in the validation set (right panel). 
Considering raw data, the Youden index ranged from 0.61 to 0.81 in the training set and from 
0.46 to 0.73 in the validation set. Among the 16 models with ID=1 (Youden index= 0.81), the 
chosen one included 35 miRNAs (Figure 1A). However, an alternative choice could be the one 
selected within the ID=8 group (Youden index=0.61), which included three miRNAs, i.e. miR-
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451, miR-16 and miR-486-5p; such a model achieved the highest classification performance in 
the validation set (Youden index= 0.73). 
Regarding ratio data, the Youden index ranged from 0.61 to 0.73 in the training set and from 
0.58 to 0.77 in the validation set. The chosen model included 500 ratios (Youden index=0.73), 
corresponding to 88 features. Alternative choices could be the model with ID=8, including two 
ratios (miR-486-5p/miR-4257 and miR-92a/miR-4257) or that with ID=5, including 4 ratios (miR-
486-5p/miR-4257, miR-92a/miR-4257, miR-486-5p/miR-4286, miR-4286/miR-451), the latter 
presenting a slightly better classification performance in the training set (Youden index=0.65 vs 
0.61); also in this case, the two parsimonious models had the best performance in the 
validation set (Youden index=0.77). It is worth to notice that with ratio data the miR-16 would 
not have been selected, since the top ratios contained more than once the other hemolysis-
related miRNAs, producing redundancy in the results. 
Globally, we noticed that the SVM cost parameters, which control model complexity, were 
smaller with the ratio data and that, regardless the type of data, it was more difficult to 
validate a model containing a large number of miRNAs. Moreover, in the validation set the 
Youden index showed wide bootstrap confidence intervals (CI), due to the small sample size. 
 
Conclusions 
In the present work we developed a general analysis strategy in order to deal with some issues 
arising in the supervised analyses of plasma miRNA from hybridization array data. In the data 
pre-processing step, any normalization method can be applied and does not preclude the 
subsequent conduction of supervised analyses, although contributing to the final results. The 
normalization method should be chosen in relation to the type of features, their precision level 
and to the domain knowledge (e.g. possible availability of housekeeping features). While in our 
investigation we adopted a joint analysis of raw and ratio-normalized data, other methods might 
be suitable, like for instance the quantile method, previously shown to work best in reducing 
differences in miRNA expression values for tissue samples [42]. We just considered inappropriate 
the application of the global mean method, which would artificially produce down-regulated 
miRNAs. Such a problem was clearly demonstrated in the case of an expected general miRNA 
down-regulation as a consequence of inducible deletion of Dicer1 [43]. This is in contrast with 
the expectation of a global miRNA up-regulation in patients with cancer as a consequence of a 
passive (i.e. cancer cell death) or active (i.e. by microvesicles) release in bloodstream. To 
establish which miRNA in a ratio has relevant  discriminating role and which act as normalizer 
(no modulation, i.e. FC=1, or presenting weaker modulation) the results of raw and ratio data 
analyses should be interpreted together. An advantage of the ratio method is that, in the 
absence of known housekeeping miRNAs, it allows identification and automatic handling of a 
specific normalizer for each DE miRNA.  
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In class comparison analysis, the search for DE features is usually intended for detecting 
significantly different means in the two groups, and location tests, such as the t-test, are 
commonly applied; this classifies class comparison analysis in the domain of univariable 
statistical analyses. However, the t-test assumption of normality is often not fulfilled when 
dealing with plasma miRNA data, mainly due to the skewed, heavy-tailed or multimodal 
distributions of expression values, especially if associated with small sample size. Moreover, 
focusing only on location, the t-test could miss miRNAs with a signal translating into more 
general differences between the distributions. Our strategy of combining the results of t- and 
AD tests was aimed at taking advantage of their different characteristics and allowed us to 
discover those miRNAs discarded by the t-test due to not significant FC, but with not 
overlapping feature distributions. The AD test is particularly valuable when distributions differ 
in the tails, which could reveal underlying biological differences. Class comparison analysis is a 
useful tool for detecting DE features; however, in our opinion caution should be taken in using 
it for ranking purposes. Indeed, by using the bootstrap selection in the first step of class 
prediction analysis, together with the application of the three machine learning algorithms 
(Elastic SCAD SVM, RF, PAM), more robust and possibly generalizable results can be obtained. 
Together with the bootstrap selection, we want to point out the egg-shaped plot, which can be 
used as a tool for giving an insight of interconnections among the selected features, becoming 
useful for highlighting their inherent biological dependences. 
In the second step of the class prediction analysis, the classifiers are obtained by using 
statistical models including subgroups of selected features, and this categorizes class 
prediction in the domain of multivariable statistical analyses. The joint use of bootstrap 
selection and classifier cross validation should ensure the robustness of the class prediction 
results. A limitation of the procedure is that we could identify several best models in terms of 
classification performance. In some cases (especially using ratio data) the best models included 
a large number of features, thus being more prone to overfitting. However, we observed that 
the use of a small number of strongly predictive features resulted in a non significant decay of 
the cross validated classification performance measures in the testing set. Therefore, our 
strategy was to choose more parsimonious models, since is likely that the features included in 
such models will not be filtered out during the data pre-processing step. However, our results 
have to be taken with caution due to the small sample size, as it emerged from the large 
bootstrap intervals of the classification performance measures. By using our strategy we 
identified four top miRNAs (miR-486-5p, miR-92a, miR-451, miR-16) that have been reported in 
the literature as related to the presence of hemolysis, together with another one (miR-22), 
which is worth to further investigate. Even though miR-22 was not directly described as 
hemolyis-susceptible miRNA, it was identified as a signature miRNA for erythrocyte maturation 
[44]. In addition, very recently MacLellan et al., by mimicking hemolysis through mechanical 
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lysis of blood samples in healthy individuals, found higher levels of serum miR-22 in lysed 
compared to matched unlysed samples ([45], Figure 1). Regarding the top miRNAs, we obtained 
consistent results in class comparison and bootstrap selection; indeed, strong signals are 
detectable on both raw and ratio data, even with univariable and not cross validated analyses. 
However, univariable methods unavoidably discard features that would have provided useful 
information, if taken in aggregate. More subtle differences, like those we observed for miR-22, 
could justify the use of more sophisticated methods, such as the bootstrap selection joined 
with the machine learning algorithms. The concordance of our results with literature data also 
corroborated the ability of the HS to discriminate between hemolyzed and not-hemolyzed 
samples and thus its usefulness as a pre-analytic hemolysis detector.  
Classifier development should rely on availability of three distinct datasets for training, 
validation, and testing. We are aware that a limitation of the present study is the lack of 
availability of a testing set on which an unbiased assessment of classifier performance could be 
obtained. Unfortunately, three-fold splitting was not applicable in our case study, because was 
hampered by the small number of hemolyzed samples, and suitable public datasets (i.e., data 
from Agilent miRNA hybridization array coupled with hemolysis score evaluation) were still 
unavailable.  
Our strategy may be extended to other kinds of ’omics’ studies by introducing proper 
methodological adjustments. For instance, with non-coding RNA Sequencing data, which are 
count variables, the Anderson-Darling test could be used for class comparison analysis; in class 
prediction analysis, models suitable for analyzing count data should be used (i.e. Negative 
Binomial, Poisson distribution based models). 
To conclude, in this study we implemented a global strategy for the analysis of plasma miRNAs. 
In class comparison the combination of the results of the t- and the AD tests can be considered 
valuable to detect miRNAs with significant FC or more general distributional differences 
between classes, which could reveal hidden differential biological processes worth to be 
considered for building predictive tools. The use of robust miRNA selection procedure together 
with multivariable modeling as a strategy employed in class prediction can guarantee result 
generalizability and be useful to explore the interconnections among the selected miRNAs, 
which are essential for highlighting their inherent biological dependences. 
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Figures 
 
Figure 1. Results of the first step of class prediction performed in the training set raw data. A) Bootstrap 
occurrences of the top 35 miRNAs included in the chosen model. B) Egg-shaped plot. A filter was applied to show 
only the features with at least 300 co-occurrences. C) Bootstrap co-occurrences of the most interconnected miRNAs. 
 
 
Figure 2. Results of the second step of class prediction performed in the training set raw and ratio data. 'ROC 
space' plot representing the classification performance of different models for class prediction in terms of false 
positive rate (FPR) and true positive rate (TPR) in the training set raw data (Panel A) and ratio data (Panel B). As 
true for the ROC curves, ideal models are those closest to the point (0,1), corresponding to 100% sensitivity and 
specificity.
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Tables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Model classification performance measures in the training and validation sets with raw and ratio data. 
 
Abbreviations. ‘Group ID’: ID of the groups of best performing models; ‘N models’: number of models in each group, 
showing a specific classification performance; ‘Sens’: sensitivity; ‘Spec’: specificity; ‘N miR’: number of miRNAs included in 
the model chosen in each group for containing the smallest number of miRNAs; ‘SVM cost’: cost parameter of the linear 
SVM model; ‘SVM weights’: weight parameter of the linear SVM. In the last three columns, testing set classification 
performance measures are reported together with the corresponding bootstrap 95% confidence intervals (CI).
 
Classification performance of the best performing 
groups of models evaluated in the training set 
 
Parameters of the chosen 
model 
Classification performance of the chosen model 
evaluated in the testing set 
Group ID N 
models 
Sens 
 
Spec 
 
Youden 
 
N 
miR 
SVM 
Cost 
SVM 
Weights 
Sens [CI] Spec [CI] Youden [CI] 
Raw data 
1 16 0.85 0.96 0.81 35 10 (0.5; 0.5) 0.77 [0.54-0.92] 0.77 [0.61-0.92] 0.54 [0.23-0.81] 
2 5 0.77 1.00 0.77 35 1 (0.5; 0.5) 0.85 [0.61-1.00] 0.81 [0.65-0.92] 0.65 [0.38-0.85] 
3 2 0.77 0.96 0.73 30 1 (0.5; 0.5) 0.85 [0.61-1.00] 0.85 [0.69-0.96] 0.69 [0.42-0.88] 
4 16 0.85 0.88 0.73 40 10 (0.5; 0.5) 0.77 [0.54-0.92] 0.73 [0.54-0.88] 0.50 [0.19-0.77] 
5 5 0.77 0.92 0.69 35 1 (0.4; 0.6) 0.85 [0.61-1.00] 0.73 [0.54-0.88] 0.58 [0.31-0.81] 
6 16 0.85 0.85 0.69 50 10 (0.5; 0.5) 0.85 [0.61-1.00] 0.69 [0.50-0.88] 0.54 [0.27-0.81] 
7 19 0.77 0.88 0.65 40 1 (0.4; 0.6) 0.77 [0.54-0.92] 0.69 [0.50-0.85] 0.46 [0.15-0.73] 
8 5 0.69 0.92 0.61 3 100 (0.4; 0.6) 0.77 [0.54-0.92] 0.96 [0.88-1.00] 0.73 [0.46-0.92] 
9 20 0.77 0.85 0.61 5 10 (0.4; 0.6) 0.69 [0.46-0.92] 0.92 [0.81-1.00] 0.61 [0.35-0.85] 
Ratio data 
1 1 0.92 0.81 0.73 500 (88) 0.01 (0.2; 0.8) 0.92 [0.77-1.00] 0.65 [0.46-0.85] 0.58 [0.31-0.81] 
2 1 0.77 0.92 0.69 17 (16) 0.01 (0.3; 0.7) 0.77 [0.54-0.92] 0.92 [0.81-1.00] 0.69 [0.42-0.92] 
3 1 0.69 1.00 0.69 90 (50) 0.01 (0.5; 0.5) 0.69 [0.38-0.92] 1.00 [1.00-1.00] 0.69 [0.38-0.92] 
4 2 0.85 0.85 0.69 150 (66) 0.01 (0.2; 0.8) 0.92 [0.77-1.00] 0.69 [0.50-0.85] 0.61 [0.38-0.81] 
5 35 0.69 0.96 0.65 4 (5) 0.1 (0.5; 0.5) 0.77 [0.54-0.92] 1.00 [1.00-1.00] 0.77 [0.54-0.92] 
6 4 0.77 0.88 0.65 500 (88) 0.01 (0.4; 0.6) 0.92 [0.77-1.00] 0.77 [0.58-0.92] 0.69 [0.46-0.88] 
7 3 0.85 0.81 0.65 600 (88) 0.01 (0.2; 0.8) 0.92 [0.77-1.00] 0.65 [0.46-0.85] 0.58 [0.31-0.81] 
8 11 0.61 1.00 0.61 2 (3) 0.1 (0.5; 0.5) 0.77 [0.54-0.92] 1.00 [1.00-1.00] 0.77 [0.54-0.92] 
9 23 0.69 0.92 0.61 3 (4) 0.1 (0.4; 0.6) 0.77 [0.54-0.92] 0.96 [0.88-1.00] 0.73 [0.50-0.92] 
10 54 0.77 0.85 0.61 4 (5) 0.1 (0.3; 0.7) 0.77 [0.54-0.92] 0.88 [0.73-1.00] 0.65 [0.38-0.88] 
11 18 0.61 0.96 0.58 3 (4) 0.1 (0.5; 0.5) 0.77 [0.54-0.92] 1.00 [1.00-1.00] 0.77 [0.54-0.92] 
12 59 0.69 0.88 0.58 2 (3) 10 (0.4; 0.6) 0.77 [0.54-0.92] 1.00 [1.00-1.00] 0.77 [0.54-0.92] 
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Additional Figures 
 
Additional figure 1. Workflow of the strategy used for sample processing, data pre-processing and supervised 
data analyses. 
 
 
Additional figure 2. Class comparison results in the training set with raw and ratio data. T-test volcano plots and 
concordance plots between t- and Anderson-Darling (AD) test for raw data (panels A and B) and ratio data 
(panels C and D).  
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5.2 Secondary ElectroSpray Ionization-Mass Spectrometry data 
 
Secondary electrospray ionization-mass spectrometry and a novel 
statistical bioinformatic approach identifies a cancer-related profile in 
exhaled breath of breast cancer patients: A pilot study 
 
Abstract 
Breath analysis represents a new frontier in medical diagnosis and a powerful tool for cancer 
biomarker discovery due to the recent development of analytical platforms for the detection 
and identification of human exhaled volatile compounds. Statistical and bioinformatic tools may 
represent an effective complement to the technical and instrumental enhancements needed to 
fully exploit clinical applications of breath analysis. Our exploratory study in a cohort of 14 
breast cancer patients and 11 healthy volunteers used secondary electrospray ionization-mass  
spectrometry (SESI-MS) to detect a cancer-related volatile profile. SESI-MS full-scan spectra were 
acquired in a range of 40-350 mass-to-charge ratio (m/z), converted to matrix data and analyzed 
using a procedure integrating data pre-processing for quality control, and a two-step class 
prediction based on machine learning techniques, including a robust feature selection, and a 
classifier development with internal validation. MS spectra from exhaled breath showed an 
individual-specific breath profile and high reciprocal homogeneity among samples, with strong 
agreement among technical replicates, suggesting a robust responsiveness of SESI-MS.  
Supervised analysis of breath data identified a support vector machine (SVM) model including 8 
features corresponding to m/z 106, 126, 147, 78, 148, 52, 128, 315 and able to discriminate 
exhaled breath from breast cancer patients from that of healthy individuals. Our data highlight 
the significance of SESI-MS as an analytical technique for clinical studies of breath analysis and 
provide evidence that our noninvasive strategy detects volatile signatures that may support 
existing technologies to diagnose breast cancer. 
Introduction 
High-throughput platforms for cancer biomarker discovery are currently focused largely on  
genomic and proteomic studies. A complementary approach consists in comparing the entire  
metabolome profile of clinical samples to detect the significant metabolic changes occurring in  
cancer cells [1]. Metabolomics reflects changes in phenotype and thus function, thereby  
representing a powerful tool in addition to genomic and proteomic-based approaches to detect  
cancer development [2]. Cancer metabolites can be studied in virtually all body fluids including 
human breath. In this context, ‘breathomics’ has recently been defined as the metabolomic  
study of exhaled air mainly focusing on the characterization of health-related volatile organic  
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compounds (VOCs) [3,4]. Human breath analysis-based diagnosis has unique advantages,  
including simplicity, safety, minimal invasiveness, painlessness and readily acceptance by  
patients. Once fully developed, the use of such techniques may be particularly appropriate not  
only in early diagnosis, but also in on- and off-line management of pediatric patients, in all  
medical conditions requiring frequent diagnostic assessments and in monitoring therapeutic  
protocols or during the surgical procedures [5,6]. In breast cancer (BC), about 60% of  diagnosed 
invasive BCs remain localized at the time of diagnosis and the 5 year-survival is  nearly 100%; 
however, survival rates drop to 85% and 25% if regional or distal tissue invasion occurs, 
respectively [7]. Noninvasive identification of molecular markers that pinpoint small lesions, 
invisible by imaging techniques, could greatly improve the cure rate of BC and reduce its related 
mortality. Indeed, reports indicate that BC can be detected by canine olfaction [8] and by gas 
chromatography (GC)/ mass spectrometry (MS) [9].   
Interest in studies aimed at identifying clinically relevant exhaled compounds, as pioneered by  
Pauling et al. [10], has led to a significant development of appropriate analytical techniques for  
the detection and identification of human exhaled VOCs [11-14]. One such technique, secondary 
electrospray ionization MS (SESI-MS) [15,16], has been shown to efficiently detect trace gas-
phase compounds in breath or in any other matrix in real time [17]. While this technology has 
recently been used to identify bacterial pathogens [18,19] and to characterize potential 
differences between patients with chronic obstructive pulmonary disease [20], dedicated 
statistical and bioinformatic tools that complement the technical and instrumental 3 
enhancements in analyzing breath-derived data are still lacking [21].  
Our present study, exploring the value of SESI-MS technology together with novel statistical  
analysis tools in cancer biomarker discovery, supports the notion that this approach can identify 
a cancer-related volatile signature able to discriminate exhaled breath of BC patients from that 
of healthy controls. 
Materials and methods 
Subjects  
A total of 25 women participated to this study, including 14 BC patients (cases) and 11 healthy 
volunteers (controls). Before surgery, patients were diagnosed with BC following the standard  
procedure in Fondazione IRCCS Istituto Nazionale dei Tumori; none of the patients received  
pharmacological treatment before breath sampling. Participants were asked not to smoke, eat,  
drink (except water), brush their teeth or use lipstick for at least 2 h before analysis. The study  
was approved by the Medical Ethics Committee of Fondazione IRCCS Istituto Nazionale dei  
Tumori (INT 122/14).  
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Sample collection  
Breath samples were collected on 4 different days into 2-L inert plastic bags with a valve and  
disposable mouthpiece (ISB, Gerenzano, Italy) previously sterilized at 40°C and 500 mTorr in the 
presence of H2O2. For 22 subjects (12 cases and 10 controls), 2 replicates were sampled within 5 
minutes. To minimize variability in sample collection, storage and processing, human breath was 
sampled within 10 days in the same conditions for cases and controls, and plastic bags containing 
human breath were kept at 10ºC until analysis by SESI within 2 h of collection [22] using a mass 
spectrometer dedicated exclusively to analysis of breath samples.  
 
Mass spectrometry  
Mass spectrometer HCT Ion Trap (Bruker Daltonics, Billerica, MA, USA) coupled to a lab-built SESI 
source [17] was operated in the positive ion mode. Full-scan spectra were acquired in a range of 
40-350 m/z; ion source parameters were capillary 3800 V, dry gas 2 L/min and temperature 
40°C. The MS instrument was slightly modified to allow admission of exhaled breath as described 
[22]. ES buffer (0.1% formic acid in H2O) was infused at a flow rate of 130 nL/min by a syringe 
pump located outside the instrument [23].  
 
Data acquisition and conversion to matrix  
Hystar software (Bruker Daltonics, Breme, Germany) was used for data acquisition. MS spectra 
data of the volatile fraction were converted to the ascii xy format using Data Analysis software 
(Bruker Daltonics, Breme, Germany) and analyzed using the NIST database approach for pattern 
recognition [24]. Custom Perl (http://www.perl.org/) script served to optimize absolute values 
of each MS signal by approximating m/z and eliminating decimal places, with values then 
included in a [feature x sample] matrix.  
 
Statistical and bioinformatic methods   
Analyses were carried out using R software, version 2.15.2 and Bioconductor. Test results were 
considered significant at p-value < 0.05.  
 
Data pre-processing  
Data pre-processing (Figure 1) included five steps. Steps I, III, IV refer to analytical procedures  
for data quality control using statistical and bioinformatic methods imported from gene  
expression studies. Step I involved assessment of concordance between technical replicates 
using concordance and Bland-Altman plots [25] and estimation of the Lin’s concordance  
correlation coefficient (CCC) [26] with the corresponding bootstrap 95% confidence interval [27], 
based on a user-defined R function, which exploits the epi.ccc function included in the epiR 
package. The Bland-Altman plot identified possible outliers, i.e., replicates outside the 
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confidence bands, the mean of which could be a biased estimate of  the true value. In step II, 
features not detected in at least 50% of samples were filtered and  discarded. Step III was data 
normalization [28] using the quantile method (normalizeBetweenArrays function in limma 
package) to impose the same empirical feature distribution to each subject. Batch effects 
arising from different dates of sample collection (step IV) were corrected using the ComBat 
(Combating Batch Effects When Combining Batches of Gene Expression Microarray Data) method 
[29]. The ComBat function in the sva R package was used for this task. Dendrograms based on 
hierarchical clustering of subjects before and after Combat correction were generated to 
visualize the effectiveness of adjustment for batch effects. Subjects were identified according 
to dates of sample collection (batches); average linkage was used as the linkage criterion to 
construct the hierarchical cluster tree and distance was measured as one minus the Spearman 
correlation coefficient [30] such that 2 subjects exhibiting a strong positive correlation are 
closer, possibly reflecting the same feature profile between paired subjects. The heatmap.2 
function in the gplots package was used to perform hierarchical clustering. In step V, missing 
values in feature replicates were imputed after data normalization as described by Karpievitch 
et al. [31].  
 
Supervised analyses  
Class comparison was performed using the nonparametric Wilcoxon-Mann-Whitney test,  
adjusting p-values for multiple testing by the Benjamini-Hochberg method [32] to control for  
false-discovery rate (FDR); class prediction involved ‘bootstrap feature selection’ [33], followed  
by classifier development and its internal validation (Figure 1). In the first step, 1000 bootstrap  
samples were drawn from the original dataset and the features were robustly ranked according  
to the proportion of bootstrap samples in which they were jointly identified as independent class  
predictors by 3 different classification algorithms, i.e. prediction analysis for microarrays (PAM)  
[34], random forest (RF) with Boruta feature selection [35] and SVM algorithm with L1- 
penalization (L1 SVM) [36] or, alternatively, elastic smoothly clipped absolute deviation (elastic 
SCAD) SVM [37]. An egg-shaped plot was initially used to summarize the bootstrap-derived 
feature  occurrences (nodes) and co-occurrences (edge thickness). The larger the node, the 
more often  the corresponding feature occurred in the bootstrap samples; the thicker the edge 
between two  nodes/features, the more often they were selected together in the bootstrap 
samples. Bootstrap selection was performed using modified doBS and importance igraph 
functions in the bootfs  package. To develop the cross-validated classifier, we applied linear SVM 
models, well- established machine-learning techniques used for high-dimensional data such as 
‘omics’ data [38-39]. A linear SVM model, implemented using the function svm in the e1071 
package, requires the tuning of only two parameters (cost parameter and class weights). Models 
were fitted by varying parameters and number of included features, forwardly selected 
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according to the bootstrap-generated list. Each model was then internally validated using a 
leave-one-out cross-validation (LOOCV) procedure to optimize parameters and estimate the 
model classification ability by computing sensitivity, specificity and Youden index (sensitivity + 
specificity − 1). The false-positive rate (FPR, 1 − specificity) and true-positive rate (TPR, 
sensitivity) were graphically represented in the ‘ROC space’ plot, which can be seen as a 
generalization of the ROC curve representing the classification performance of the different 
linear SVM models. The final model used to develop the classifier was chosen based on both best 
classification performance, as indicated by the highest Youden index, and smallest number of 
features included in the model. The heatmap was generated by clustering feature values and 
using the ‘one minus the Spearman correlation coefficient’ as distance metric and the average 
linkage as linkage criterion.   
‘Feature importance analysis’ was performed by generating 1000 permuted data sets and  
running the L1 SVM-based bootstrap selection procedure on each random data set. The best 3  
features of each selection were extracted, compared to the features bootstrap-selected on not  
permuted original data and the co-occurrence in permuted and original datasets were 
calculated. 
Results 
Exhaled breath from BC patients and healthy controls were sampled in duplicate within 2 hours  
before SESI/MS analysis. Patients’ breath samples were collected 3-24 hours before surgery.  
Histology confirmed the presence of a tumor mass at the time of sampling. Clinical and 
pathological characteristics of patients revealed consistency in BC consecutive cohorts, i.e., 
average tumor size 2 cm, 64% node-negative tumors, 71% ER (Estrogen Receptor) positive, and 
71% grade I-II.  
 
Data pre-processing  
MS spectra from exhaled breath of a subject were highly similar in replicates and each  
participant showed an individual-specific breath profile (Figure 2A), consistent with previous  
studies [22,40,41]. Breath mass spectra were processed and converted to a final matrix  
including 351 features and 47 samples (16497 total values). About 17% of values (2838/16497)  
were missing and equally distributed between the first and second replicates and between  cases 
and controls, suggesting that missing values were missing at random (MAR). In step I of data pre-
processing (Figure 1), the concordance correlation coefficient (CCC, Figure 2B) for the 22 
subjects with technical replicates, together with the  concordance plots and the Bland-Altman 
plots, confirmed the  agreement between technical replicates (CCC range: 0.89-0.99). Overall, 
variability of SESI-MS  measurements was higher for signals in the low-abundance region. Based 
on the concordance analysis, the mean of the two replicate values for each feature in each 
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sample was calculated and, after filtering (step II), 296 features remained for subsequent 
analyses. Based on the above results and considering the quality and characteristics of SESI 
breath data and their matrix data structure, statistical and bioinformatics tools for data pre-
processing and supervised analyses of gene expression data were applied. After quantile 
normalization (step III) and Combat correction (step IV), the dendrogram obtained from 
hierarchical clustering indicated grouping of samples independent of daily batches. Seventy 
values missing in both replicates and occurring in 18 samples and 30 features were imputed  
using the median of each feature (step V) under the MAR assumption.  
 
Classifier development  
The resulting data matrix [296 features x 25 subjects] was further statistically analyzed in a  
supervised setting (Figure 1) in an effort to identify signals reflecting exhaled compounds that  
may be valuable in identifying BC, based on the mass spectrometric fingerprints. Class  
comparison revealed 35 features in breath that differed significantly between cases and controls  
(Figure 3), 24 (69%) of which were present at higher levels in the exhaled breath from cases. 
This subset included the features with m/z 148 and 128, showing FDR-adjusted p-values of 
0.0259 and 0.0770, respectively (nominal p-values: 9e-05 and 5e-04). In class prediction analysis, 
we first attempted to identify the most informative signals using the bootstrap feature selection 
strategy, based on 3 different classification algorithms: PAM, RT and L1 SVM. Bootstrap results 
are represented by an egg-shaped plot (Figure 4A) that provides an immediate overview of the 
feature relevance in terms of bootstrap occurrence (node size) and co-occurrence (edge 
thickness); the latter can suggest possible structural and/or biological links among molecules. 
The signal detected at m/z 106, selected in 346 of 1000 bootstrap samples was the most 
discriminative, followed in decreasing order by signals at m/z 126 and 147 (345 of 1000), 78 (331 
of 1000), 148 and 52 (322 of 1000) and 128 (259 of 1000). Figure 4B shows the frequency of 
bootstrap occurrences and co-occurrences of the features represented in the egg-shaped plots. 
The most frequent co-occurrences involved feature corresponding to m/z 126 and were jointly 
selected with feature 147 (202 of 1000 bootstrap samples), 148 (190 of 1000), 128 (185 of 1000) 
and 315 (160 of 1000); note that signal at m/z 148 co-occurred with its isotope at m/z 147 (161 
of 1000). Signals selected in at least one bootstrap sample were used in a multivariable context 
to develop a cross-validated linear SVM classifier. The ‘ROC space’ in Figure 5A shows the results 
of the different SVM models in terms of cross-validated classification performance. The model 
with sensitivity = 0.93, specificity = 0.91 and Youden index = 0.84, including 8 features (m/z 
106, 126, 147, 78, 148, 52, 128, 315) was used to develop the classifier, characterized by the 
best performance in discriminating exhaled breath from BC patients and by the smallest number 
of features among the models with equal  discriminating performance. Figure 5B shows a heat 
map representing the abundance of the 8 features in each sample. Overall, supervised analysis 
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indicated that the mass regions, 147-148, 126-128, 106 and 315 included signals originating from 
molecules possibly chemically and/or functionally related and differentially over-detected in 
exhaled breath of BC patients.  
The bootstrap feature selection was also performed by applying the elastic SCAD SVM, in  
conjunction with PAM and RF, obtaining similar results as those achieved using L1-SVM. Both 
feature selection algorithms clearly tends to pick isotopic features (e.g., m/z 147-148), 
suggesting that they efficiently selects interconnected signals.   
Finally, to ensure that the discriminative features were not selected merely by chance, we 
calculated how often the 8 features of the final classifier were the top 3 in the bootstrap 
selection classifications obtained from 1000 permuted data sets, in which a random association 
between features and classes (cases and controls) was generated. None of the 8 features was 
selected as top 3 in 848 permuted data sets, one of the 8 features was top 3 in 141 selections, 
and a couple of features appeared jointly in 11 selections. The most predictive feature, i.e.106, 
appeared 2% of the times as top 3; the corresponding percentages for the other features were: 
0.4% for 126 and 147, 5.9% for 78, 0.1% for 148, 7.2% for 52, 0.2% for 128 and 0.1% for 315. This 
indicates that the 8 BC–related features were randomly bootstrap-selected in permuted 
datasets, supporting the robustness of the classifier. 
 
Discussion 
The recent dramatic improvement of analytical platforms for metabolic profiling has provided 
evidence encouraging the use of metabolic biomarkers as a valuable tool for cancer detection 
[1]. In the case of biomarker discovery in exhaled breath, sample handling, chemical analysis 
and subsequent data mining await standardization after further exploration of novel and suitable  
approaches. In particular, there is a well-identified need for defining data pre-processing  
techniques and supervised methods in breath analysis, as recently highlighted by Smolinska and 
coworkers [21]. Here, we explored the clinical usefulness of a combination of a promising breath 
analytical tools, i.e., SESI-MS, and a statistical and bioinformatic tool for data pre-processing 
and classifier development. Using this novel strategy, we identified a BC-related signature able 
to classify patient and control breathprints with sensitivity and specificity above 0.9.  
Because all ‘omics’ studies are generally affected by several sources of variability, including  
inherent biological variation as well as data noise due to intrinsic technical variability, there is a  
need for efficient governance of non-biological variability in the pre-analytical and analytical  
phases to minimize data misinterpretation. One of the main advantages of the analytical 
platform used herein resides in the rapid screening of breath metabolites made possible by SESI-
MS, resulting in rich MS fingerprints without any sample preparation. Indeed, the complete SESI-
MS analysis of two replicate samples collected in appropriate bags was typically accomplished in 
less than one minute. The accuracy of replicate profiles and high reciprocal homogeneity among 
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all samples suggest the robustness of SESI-MS measurements. In addition, data produced using 
SESI-MS analysis were high-dimensional data of quality comparable to gene expression analysis 
output, prompting us to use methods originally developed for gene expression data in analyzing 
SESI-MS breathprints. Together, the properties of SESI-MS suggest its particular suitability for 
large-scale clinical breath analyses.  
In the post-analytical step, we used data pre-processing techniques to correct for residual  
systematic technical or non-biological experimental variation. The Combat correction, in  
particular, was used to adjust for batch effects arising from the breath sample collection 
procedure and analysis performed on different days.   
With the aim of developing a VOC signature that accurately discriminates between cases and  
controls, we used a two-step procedure involving current and new approaches for data analysis  
and representation that promises to ensure generalization of results and provide insights into 
feature interconnections. Bootstrap feature selection raised a robust and specific feature 
ranking, as supported by the random selection of the BC-related features when the bootstrap 
procedure was applied to 1000 permuted datasets. The bootstrap feature selection was based on 
conceptually different machine-learning algorithms: PAM, RF and two alternative SVM  
algorithms, i.e. L1 or elastic SCAD. The above algorithms were chosen because they can  
overcome the ‘curse of dimensionality’ typical of ‘omics’ data, i.e., feature numbers much 
larger than subject numbers, and are representative of methodological categories using 
different decision rules for classification. PAM provides simplicity and interpretability, while RF 
and SVMs algorithms are suitable for complex classification patterns. RF is nonparametric, which 
is desirable especially when outliers occur, and also deals with data overfitting; however, RF 
only outputs importance measures, the interpretation of which is controversial in the presence 
of correlated features [42]. The recent elastic SCAD SVM [37] has been proposed as an effective 
method for considering the correlation structures in the input data (grouping effect) and applied 
to develop a miRNA-based classifier able to discriminate hemolyzed and not hemolyzed plasma 
samples [42]. The L1-SVM showed high prediction accuracy for models in which the sparsity 
assumption (small number of nonzero parameters) is tenable [36], as in the case of ‘omics’ data 
characterized by few predictive variables. In our application the two alternative SVM algorithms 
generated comparable bootstrap feature rankings, but the computation time of bootstrap 
process was dramatically reduced using L1-SVM jointed to PAM and RT, addressing this setting of 
our pipeline to biomarker discovery in large cohort of patients. We summarized the bootstrap 
feature selection in an egg-shaped plot, allowing immediate visualization of the most 
discriminative features and their co-occurrences and highlighting the possible interconnections 
underlying the structural/biological framework usually hidden in massive data. Lastly, we 
derived a molecular signature associated with cancer patient breath samples using a linear SVM 
model based on the ‘rule’ of best classification performance, as indicated by the highest Youden 
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index, and smallest number of features included in the model. Linear SVM models require the 
tuning of only two parameters but, like all SVM models, do not  allow probability estimation or 
ROC curve generation; nevertheless, a binary classifier can be easily derived from SVM 
predictions, since they cluster around two different values.  
While conclusions from our study are limited by our small sample size, our statistical and  
bioinformatic strategy for breath analysis has already been adapted to other ‘omics’ data,  
including microRNA data [42] and a complex LC-MS dataset from high-resolution Orbitrap  
analysis of plasma samples (Landoni, Miceli and Orlandi, in preparation). This indicates that our  
procedure is flexible enough to adapt the algorithm to different questions, data structure or 
knowledge domain.  
The present study designed a general strategy effective in discovering potential volatile  
biomarkers to be developed for early diagnosis of cancer. The classification performance of our  
volatile signature awaits confirmation in larger cohorts of BC patients and non-cancer control  
subjects. Another important aspect is the identification of the most discriminative exhaled  
compounds to gain insights into the disease. This task can be undertaken by combining SESI with 
mass spectrometers of high resolution and fragmentation capabilities, thereby enabling  
unambiguous identification [44, 45].  
The translation of the biomarker discovery phase to the clinical practice, beyond the validation  
phase, will still require a significant development of the analytical and bioinformatics 
procedures, tailored on the definitive classifier, to finally deliver a user-friendly tool for the 
rapid, simple and  precise detection of cancer-related signals by breath analysis. 
 
Conclusion 
Overall, our study supports the value of SESI-MS as an analytical technique for clinical studies,  
since it allows rapid collection of rich metabolic breathprints, and underscores the importance 
of  sample quality assessment and quality control of raw data from breath analysis using a robust  
data pre-processing techniques to address unbiased pattern discovery. Our identification of a  
potential cancer-related volatile signature that identifies BC patients based on their exhaled 
metabolic breathprint provides the foundation and rationale for further analyses aimed at  
developing a noninvasive diagnostic tool for prediction of BC.  
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Figures 
 
Figure 1. Workflow for data pre-processing and supervised analyses.  
 
Figure 2. Quality control of pre-analytical and analytical procedures in data pre-processing. A) Evaluation of MS 
spectra quality based on NIST comparison of MS spectra from exhaled breath of two replicates from randomly selected 
subjects. B) Concordance analysis of replicates based on concordance correlation coefficient (CCC) and corresponding 
95% bootstrap confidence interval (CI) for each subject.  
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Figure 3. Class comparison analysis. Boxplots showing the distribution of the ion abundance values of the 35 
significantly differentially detected features in cases (dark grey) versus controls  (light grey), sorted in ascending 
order according to the Wilcoxon test p-value. 
 
 
Figure 4. Bootstrap feature selection. A) Egg-shaped plot representing bootstrap results and  showing features (m/z) 
with at least 150 co-occurrences. B) Frequency of occurrences (in  brackets) and co-occurrences (next to edge) of the 
features represented in the egg-shaped plot.  
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Figure 5. Classifier development. The ‘ROC space’ plot represents the LOOCV classification  performance of different 
linear SVM models for class prediction in terms of false-positive rate  (FPR; 1-specificity) and true-positive rate (TPR; 
sensitivity).  
 
6. Conclusions  
 
In the context of cancer research, we propose a pipeline for class comparison and class 
prediction analyses. In class comparison we recommend the use of the two-sample AD 
test, since our simulation study proved that it is a sensitive and flexible test able to 
detect general differences between feature distributions under different patterns, and 
thus it can keep more discriminative features than other tests for class prediction 
analysis. For the latter, we set up a two-step strategy able to robustly rank the features 
and find a parsimonious and generalizable classifier for two-class classification 
problems. We applied such a pipeline in different contexts of high dimensional data, 
adapting it on the basis of the specific data at hand. The core idea of the feature 
selection strategy is to jointly use three different and recently developed algorithms, 
each one with its pros and cons, in order to detect features that are discriminative for 
different aspects and thus be more prone to be validated with other data. Moreover, we 
paid special attention to the graphical representation of results, favoring the use of 
simple plots, which can be easily understandable also by non-statistician researchers.  
Future research will be directed to give more insights on the optimization of the Linear 
SVM parameters, the study of CV variants for model selection and the sensitivity of 
results to the use of different simulation seeds. Moreover, we aim at finding an effect  
measure in line with the AD test (like the FC for the t test) to be used in new volcano 
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plots and searching for an alternative method to the Linear SVM model for classifier 
implementation, with the possibility to use the Area Under the ROC Curve (AUC) as 
indicator of classification performance. 
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Appendix 1:R codes for Cramer-von-Mises – Podgor-
Gastwirth PG2 – Cucconi – Zhang tests 
 
User-defined codes of the implemented tests: CvM test, PG2 test, Cucconi test (asymptotic 
version), Cucconi test (empirical version), Zhang tests. 
 
 CvM test  
 
f.cvm.burr <- function(x1,x2){  
vect <- sort(c(x1,x2))  
binEdges = c(min(vect-1),vect,max(vect)+1)  
binCounts1 = hist (x1 , breaks=binEdges, plot = FALSE)$counts  
binCounts2 = hist (x2 , breaks=binEdges, plot = FALSE)$counts  
sumCounts1 = cumsum(binCounts1)/sum(binCounts1)  
sumCounts2 = cumsum(binCounts2)/sum(binCounts2)  
sampleCDF1 = sumCounts1[1:length(sumCounts1)-1]  
sampleCDF2 = sumCounts2[1:length(sumCounts2)-1]  
N1=length(x1);N2=length(x2);N=N1+N2  
CMstatistic = (N1*N2)/(N^2)*(sum((sampleCDF1 - sampleCDF2)^2))  
pValue <- 10^(-0.458-0.444*log10(CMstatistic)-2.151*CMstatistic)  
return(list(stat=CMstatistic, p.val=pValue))  
}  
 
 PG2 test  
 
f.pg2 <- function(x, y){  
Y = c(rep(0, length(x)), rep(1, length(y)))  
R = rank(c(x,y))  
pg = summary(lm(Y ~ R + I(R^2)))  
pval.pg2<-1-pf(pg$fstatistic[1], pg$fstatistic[2], pg$fstatistic[3])  
names(pval.pg2)<-NULL  
return(pval.pg2)  
}  
 
 Cucconi test (asymptotic version)  
 
f.cucconi <- function(x, y){  
n1 <- length(x); n2 <- length(y); n <- n1+n2  
R = rank(c(x,y))  
term1=(n+1)*(2*n+1)  
term2=(8*n+11)  
numU=6*sum((R[1:n1])^2)-n1*term1  
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denU=sqrt(n1*n2*term1*term2/5)  
U=numU/denU  
numV = 6*sum(((n+1-R)[1:n1])^2)-n1*term1  
denV=sqrt(n1*n2*term1*term2/5)  
V=numV/denV  
ro = (2*(n^2-4))/((2*n+1)*term2)-1  
C = (U^2 + V^2 - 2*ro*U*V)/(2*(1-ro^2))  
C.pval=exp(-C)  
return(list(stat=C,p.val=C.pval))  
}  
 
 Cucconi test (empirical version)  
 
f.cucconi.exact <- function(x,y,N=2000) {  
n1 <- length(x); n2 <- length(y); n <- n1+n2  
Sc <-0  
Rc = rank(c(x,y))  
term1=(n+1)*(2*n+1)  
term2=(8*n+11)  
numU=6*sum((Rc[1:n1])^2)-n1*term1  
denU=sqrt(n1*n2*term1*term2/5)  
U=numU/denU  
numV = 6*sum(((n+1-Rc)[1:n1])^2)-n1*term1  
denV=sqrt(n1*n2*term1*term2/5)  
V=numV/denV  
ro = (2*(n^2-4))/((2*n+1)*term2)-1  
C = (U^2 + V^2 - 2*ro*U*V)/(2*(1-ro^2))  
for (j in 1:N) {  
R <- sample(n)  
term1=(n+1)*(2*n+1)  
term2=(8*n+11)  
numU=6*sum((R[1:n1])^2)-n1*term1  
denU=sqrt(n1*n2*term1*term2/5)  
U=numU/denU  
numV = 6*sum(((n+1-R)[1:n1])^2)-n1*term1  
denV=sqrt(n1*n2*term1*term2/5)  
V=numV/denV  
ro = (2*(n^2-4))/((2*n+1)*term2)-1  
cc = (U^2 + V^2 - 2*ro*U*V)/(2*(1-ro^2))  
Sc = Sc + (cc > C)  
}  
C.pval <- Sc/N  
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return(list(C=C,p.C=C.pval))  
}  
 
 Zhang tests  
 
f.zhang.tests <- function(x,y,N=2000) {  
n1 <- length(x); n2 <- length(y); n <- n1+n2  
Sc <-0; Sa<-0; Sk<-0  
Rc <- rank(c(x,y))  
Ra <- ceiling(rank(c(x,y)))  
Rk <- ceiling(rank(c(x,y)))  
 
 f Zc test  
gc <- function(m, r, M) {sum(log(m/(1:m-.5)-1)*log(M/(r-.5)-1))}  
 
 f ZA test  
ga <- function (m, r, M) {d <- sort(r); D <- c(1,d,M+1)  
p <- rep(0:m, D[2: (m+2)]-D[1:(m+1)] )  
p[d] <- p[d]-.5; p <- p/m  
m*(p*log(p+.0000000001)+(1-p)*log(1-p+.0000000001))}  
wa <- (1:n-.5)*(n:1-.5)  
 
 f ZK test  
P <- (1:n-.5)/n  
wk <- n*(P*log(P)+(1-P)*log(1-P))  
gk <- function (m, r, M) {d <- sort(r); D <- c(1,d,M+1)  
p <- rep(0:m, D[2: (m+2)]-D[1: (m+1)])  
p[d] <- p[d]-.5; p <- p/m  
m*(p*log(p+.0000000001)+(1-p)*log(1-p+.0000000001))}  
Zc <- (gc(n1, sort(Rc[1:n1]),n) + gc(n2, sort(Rc[(n1 + 1):n]),n))/n  
Za <- -sum((ga(n1,Ra[1:n1],n)+ga(n2,Ra[(n1+1):n],n))/wa)  
Zk <- max(gk(n1, Rk[1:n1] , n) + gk(n2, Rk [ (n1 + 1) :n] , n) - wk)  
for (j in 1:N) {  
R <- sample(n)  
zc <- (gc(n1,sort(R[1:n1]),n)+gc(n2, sort(R[(n1 + 1):n]),n))/n  
za <- -sum((ga(n1,R[1:n1],n)+ga(n2, R[(n1+1):n],n))/wa)  
zk <- max(gk(n1, R[1:n1] , n) + gk(n2, R [ (n1 + 1 ) :n] , n) - wk)  
Sc = Sc + (zc < Zc)  
Sa = Sa + (za < Za)  
Sk = Sk + (zk > Zk)  
}  
Zc.pval <- Sc/N  
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Za.pval <- Sa/N  
Zk.pval <- Sk/N  
return(list(Zc=Zc,p.Zc=Zc.pval,Za=Za,p.Za=Za.pval,Zk=Zk,p.Zk=Zk.pval))  
} 
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Appendix 2: Density distributions and Empirical 
Cumulative Distribution Functions of the simulation 
patterns I-VI  
 
A2.1 Density distributions and ECDFs for λ=0.80 
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Figure A2.1. Plots of density distributions and ECDFs (δ=1 and λ=0.80) of the two simulated samples (cases in red and 
controls in green) for the six selected patterns and three sample size settings (m=20 vs n=20, m=20 vs n=40 and m=40 vs 
n=20): I. two normals; II. normal vs mixture (sh=6); III. mixture (sh=6) vs normal; IV. two mixtures with equal shifts 
(sh1=sh2=6); V. two mixtures with different shifts (sh1=3 < sh2=6); VI. two mixtures with different shifts (sh1=6 > sh2=3).  
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A2.2 Density distributions and ECDFs for λ=0.95 
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Figure A2.2. Plots of density distributions and ECDFs (δ=1 and λ=0.95) of the two simulated samples (cases in red and 
controls in green) for the six selected patterns and three sample size settings (m=20 vs n=20, m=20 vs n=40 and m=40 vs 
n=20): I. two normals; II. normal vs mixture (sh=6); III. mixture (sh=6) vs normal; IV. two mixtures with equal shifts 
(sh1=sh2=6); V. two mixtures with different shifts (sh1=3 < sh2=6); VI. two mixtures with different shifts (sh1=6 > sh2=3).  
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A2.3 Density distributions and ECDFs for λ=0.20 
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Figure A2.3. Plots of density distributions and ECDFs (δ=1 and λ=0.20) of the two simulated samples (cases in red and 
controls in green) for the six selected patterns and three sample size settings (m=20 vs n=20, m=20 vs n=40 and m=40 vs 
n=20): I. two normals; II. normal vs mixture (sh=6); III. mixture (sh=6) vs normal; IV. two mixtures with equal shifts 
(sh1=sh2=6); V. two mixtures with different shifts (sh1=3 < sh2=6); VI. two mixtures with different shifts (sh1=6 > sh2=3).  
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A2.4 Density distributions and ECDFs for λ=0.05 
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Figure A2.4. Plots of density distributions and ECDFs (δ=1 and λ=0.05) of the two simulated samples (cases in red and 
controls in green) for the six selected patterns and three sample size settings (m=20 vs n=20, m=20 vs n=40 and m=40 vs 
n=20): I. two normals; II. normal vs mixture (sh=6); III. mixture (sh=6) vs normal; IV. two mixtures with equal shifts 
(sh1=sh2=6); V. two mixtures with different shifts (sh1=3 < sh2=6); VI. two mixtures with different shifts (sh1=6 > sh2=3).  
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Appendix 3. Simulation results in terms of size and 
power (α = 0.05) 
 
Tables of the simulation results for the selected patterns under H0 (δ = 0) and H1 (δ = 1), divided 
primarily according to the mixture weight λ (λ = 0.80, λ = 0.95, λ= 0.20 and λ = 0.05) and, 
secondly, according to the sample size (m,n) ((m,n) = (20,20), (m,n) = (20,40), (m,n) = (40,20)). 
Characteristics of the two distributions X and Y and size and power estimates are reported. 
 
A3.1 Size and power for λ=0.80  
 
H0 patterns (δ=0) 
Table A3.1.1. Characteristics of X and Y distributions  
Pattern m11 m12 m21 m22 M1 M2 MED1 MED2 σ1 σ2 
I 0 0 0 0 0.0 0.0 0 0 1 1 
IV 0 3 0 3 0.6 0.6 0.3 0.3 1.6 1.6 
IV 0 6 0 6 1.2 1.2 0.3 0.3 2.6 2.6 
 
Table A3.1.2. Size estimates with (m,n) = (20,20)                                                                                                                                                         
Pattern t Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.053 0.053 0.052 0.055 0.051 0.055 0.037 0.055 0.056 0.059 0.054 0.054 
IV 0.050 0.049 0.051 0.054 0.049 0.054 0.034 0.053 0.053 0.059 0.052 0.052 
IV 0.049 0.047 0.050 0.053 0.049 0.053 0.035 0.053 0.054 0.060 0.051 0.051 
 
 
   
Table A3.1.3. Size estimates with (m,n) = (20,40)                                                                                                                                                         
Pattern t Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.053 0.054 0.050 0.048 0.045 0.049 0.041 0.051 0.051 0.052 0.052 0.051 
IV 0.053 0.051 0.049 0.052 0.049 0.052 0.042 0.051 0.051 0.052 0.053 0.053 
IV 0.049 0.053 0.048 0.051 0.049 0.052 0.042 0.052 0.052 0.052 0.053 0.051 
                                                                          
Table A3.1.4. Size estimates with (m,n) = (40,20)                                                                                                                                                         
Pattern t Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.049 0.048 0.046 0.047 0.044 0.047 0.044 0.050 0.048 0.051 0.048 0.048 
IV 0.052 0.053 0.051 0.053 0.050 0.053 0.042 0.051 0.052 0.055 0.051 0.052 
IV 0.052 0.054 0.050 0.052 0.049 0.053 0.042 0.050 0.052 0.055 0.051 0.052 
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H1 patterns (δ=1) 
 
Table A3.1.5. Characteristics of X and Y distributions  
Pattern m11 m12 m21 m22 M1 M2 MED1 MED2 σ1 σ2 
I 0 0 1 1 0 1 0 1 1 1 
II 0 0 1 7 0 2.2 0 1.3 1 2.6 
III 0 6 1 1 1.2 1 0.3 1 2.6 1 
IV 0 6 1 7 1.2 2.2 0.3 1.3 2.6 2.6 
V 0 3 1 7 0.6 2.2 0.3 1.3 1.6 2.6 
VI 0 6 1 4 1.2 1.6 0.3 1.3 2.6 1.6 
                                                                                                                                                                                                                                                                                       
 
  
Table A3.1.7. Power estimates with (m,n) = (20,40) 
Pattern t Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.947 0.944 0.936 0.881 0.875 0.881 0.858 0.925 0.932 0.857 0.921 0.918 
II 0.997 0.999 0.992 0.979 0.977 0.979 0.965 0.989 0.992 0.979 0.992 0.992 
III 0.145 0.058 0.299 0.796 0.790 0.796 0.461 0.528 0.690 0.715 0.872 0.871 
IV 0.284 0.298 0.599 0.680 0.673 0.680 0.598 0.649 0.687 0.600 0.688 0.679 
V 0.748 0.830 0.711 0.651 0.643 0.650 0.610 0.700 0.745 0.683 0.788 0.794 
VI 0.181 0.133 0.470 0.857 0.852 0.856 0.613 0.693 0.796 0.709 0.889 0.883 
  
Table A3.1.8. Power estimates with (m,n) = (40,20) 
Pattern t Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.948 0.942 0.937 0.888 0.882 0.888 0.865 0.927 0.935 0.864 0.927 0.923 
II 0.998 0.991 0.989 0.979 0.979 0.980 0.962 0.985 0.991 0.973 0.994 0.994 
III 0.016 0.064 0.257 0.686 0.675 0.684 0.432 0.505 0.539 0.657 0.588 0.633 
IV 0.279 0.248 0.624 0.610 0.597 0.608 0.617 0.674 0.675 0.637 0.655 0.656 
V 0.822 0.724 0.732 0.643 0.631 0.642 0.634 0.726 0.763 0.738 0.829 0.838 
VI 0.086 0.123 0.470 0.741 0.734 0.741 0.619 0.695 0.707 0.700 0.694 0.722 
 
 
 
 
 
Table A3.1.6. Power estimates with (m,n) = (20,20) 
Pattern t Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.869 0.868 0.849 0.757 0.745 0.755 0.698 0.834 0.848 0.752 0.839 0.834 
II 0.981 0.980 0.953 0.916 0.909 0.915 0.865 0.945 0.954 0.924 0.962 0.963 
III 0.061 0.057 0.223 0.617 0.603 0.614 0.298 0.375 0.435 0.528 0.542 0.559 
IV 0.213 0.212 0.482 0.492 0.477 0.491 0.427 0.518 0.530 0.489 0.527 0.525 
V 0.639 0.634 0.584 0.493 0.476 0.488 0.442 0.570 0.603 0.567 0.649 0.657 
VI 0.117 0.116 0.360 0.671 0.656 0.668 0.432 0.532 0.574 0.557 0.623 0.630 
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A3.2 Size and power for λ=0.95 
 
H0 patterns (δ=0) 
Table A3.2.1. Characteristics of X and Y distributions  
Pattern m11 m12 m21 m22 M1 M2 MED1 MED2 σ1 σ2 
I 0 0 0 0 0 0 0 0 1 1 
IV 0 3 0 3 0.1 0.1 0.1 0.1 1.2 1.2 
IV 0 6 0 6 0.3 0.3 0.1 0.1 1.6 1.6 
                                                                                                                                                                                                                
Table A3.2.2. Size estimates with (m,n) = (20,20) 
Pattern t Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.053 0.053 0.052 0.055 0.051 0.055 0.037 0.055 0.056 0.059 0.054 0.054 
IV 0.053 0.052 0.052 0.056 0.051 0.055 0.036 0.054 0.054 0.063 0.055 0.055 
IV 0.047 0.044 0.052 0.056 0.051 0.056 0.036 0.054 0.055 0.063 0.055 0.055 
                                                                                         
Table A3.2.3. Size estimates with (m,n) = (20,40) 
Pattern t Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.053 0.054 0.050 0.048 0.045 0.049 0.041 0.051 0.051 0.052 0.052 0.051 
IV 0.053 0.053 0.052 0.050 0.047 0.050 0.044 0.054 0.053 0.053 0.053 0.053 
IV 0.049 0.054 0.051 0.049 0.046 0.049 0.044 0.054 0.053 0.053 0.053 0.053 
 
Table A3.2.4. Size estimates with (m,n) = (40,20) 
Pattern t Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.049 0.048 0.046 0.047 0.044 0.047 0.044 0.050 0.048 0.051 0.048 0.048 
IV 0.048 0.048 0.049 0.048 0.045 0.049 0.045 0.051 0.051 0.050 0.048 0.047 
IV 0.046 0.050 0.049 0.048 0.046 0.049 0.045 0.051 0.051 0.050 0.048 0.047 
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H1 patterns (δ=1) 
 
Table A3.2.5. Characteristics of X and Y distributions  
Pattern m11 m12 m21 m22 M1 M2 MED1 MED2 σ1 σ2 
I 0 0 1 1 0 1 0 1 1 1 
II 0 0 1 7 0 1.3 0 1.1 1 1.6 
III 0 6 1 1 0.3 1 0.1 1 1.6 1 
IV 0 6 1 7 0.3 1.3 0.1 1.1 1.6 1.6 
V 0 3 1 7 0.1 1.3 0.1 1.1 1.2 1.6 
VI 0 6 1 4 0.3 1.1 0.1 1.1 1.6 1.2 
 
Table A3.2.6. Power estimates with (m,n) = (20,20) 
Pattern t Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.869 0.868 0.849 0.757 0.745 0.755  0.698 0.834 0.848 0.752 0.839 0.834 
II 0.904 0.901 0.883 0.804 0.794 0.803  0.745 0.869 0.880 0.799 0.879 0.877 
III 0.419 0.417 0.697 0.638 0.623 0.636  0.589 0.720 0.723 0.619 0.690 0.680 
IV 0.499 0.497 0.750 0.677 0.661 0.674  0.634 0.761 0.763 0.663 0.729 0.717 
V 0.729 0.726 0.770 0.682 0.666 0.680  0.636 0.768 0.772 0.669 0.745 0.737 
VI 0.485 0.483 0.743 0.680 0.663 0.678 0.634 0.761 0.764 0.663 0.733 0.722 
                             
Table A3.2.7. Power estimates with (m,n) = (20,40) 
Pattern t Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.947 0.944 0.936 0.881 0.875 0.881 0.858 0.925 0.932 0.857 0.921 0.918 
II 0.961 0.978 0.957 0.915 0.910 0.914 0.892 0.949 0.955 0.898 0.950 0.948 
III 0.547 0.460 0.811 0.803 0.796 0.804 0.765 0.833 0.849 0.747 0.856 0.846 
IV 0.614 0.596 0.858 0.829 0.822 0.828 0.804 0.866 0.876 0.788 0.853 0.840 
V 0.829 0.855 0.876 0.827 0.821 0.825 0.805 0.871 0.881 0.793 0.858 0.848 
VI 0.615 0.542 0.851 0.834 0.828 0.834 0.803 0.868 0.882 0.789 0.879 0.869 
                                                                        
Table A3.2.8. Power estimates with (m,n) = (40,20) 
Pattern t Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.948 0.942 0.937 0.888 0.882 0.888 0.865 0.927 0.935 0.864 0.927 0.923 
II 0.976 0.955 0.958 0.921 0.918 0.921 0.895 0.949 0.958 0.899 0.958 0.956 
III 0.434 0.529 0.834 0.754 0.746 0.755 0.774 0.850 0.841 0.759 0.773 0.773 
IV 0.596 0.613 0.879 0.802 0.795 0.802 0.816 0.882 0.878 0.798 0.829 0.824 
V 0.874 0.845 0.892 0.816 0.809 0.815 0.817 0.886 0.886 0.802 0.856 0.851 
VI 0.539 0.613 0.874 0.798 0.790 0.799 0.816 0.881 0.878 0.798 0.821 0.818 
 
113 
 
A3.3 Size and power for λ=0.20 
 
H0 patterns (δ=0) 
Table A3.3.1. Characteristics of X and Y distributions  
Pattern m11 m12 m21 m22 M1 M2 MED1 MED2 σ1 σ2 
I 0 0 0 0 0 0 0 0 1 1 
IV 0 3 0 3 2.4 2.4 2.7 2.7 1.6 1.6 
IV 0 6 0 6 4.8 4.8 5.7 5.7 2.6 2.6 
                                                                                                                                                                                                          
Table A3.3.2. Size estimates with (m,n) = (20,20) 
Pattern t Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.053 0.053 0.052 0.055 0.051 0.055 0.037 0.055 0.056 0.060 0.054 0.054 
IV 0.049 0.048 0.051 0.051 0.046 0.050 0.035 0.054 0.053 0.058 0.051 0.049 
IV 0.046 0.045 0.051 0.052 0.047 0.050 0.036 0.054 0.053 0.058 0.052 0.051 
 
Table A3.3.3. Size estimates with (m,n) = (20,40) 
Pattern t Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.053 0.054 0.050 0.048 0.045 0.049 0.041 0.051 0.051 0.052 0.052 0.051 
IV 0.046 0.046 0.047 0.049 0.047 0.050 0.039 0.049 0.048 0.047 0.045 0.045 
IV 0.045 0.049 0.046 0.047 0.045 0.048 0.040 0.048 0.046 0.046 0.044 0.045 
                                                                
Table A3.3.4. Size estimates with (m,n) = (40,20) 
Pattern t Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.049 0.048 0.046 0.047 0.044 0.047 0.044 0.050 0.048 0.051 0.048 0.048 
IV 0.049 0.050 0.046 0.048 0.046 0.050 0.042 0.048 0.049 0.052 0.047 0.047 
IV 0.050 0.056 0.047 0.049 0.047 0.051 0.043 0.049 0.048 0.052 0.048 0.048 
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H1 patterns (δ=1) 
 
Table A3.3.5. Characteristics of X and Y distributions  
Pattern m11 m12 m21 m22 M1 M2 MED1 MED2 σ1 σ2 
I 0 0 1 1 0.0 1.0 0 1 1 1 
II 0 0 1 7 0.0 5.8 0 6.7 1 2.6 
III 0 6 1 1 4.8 1.0 5.7 1 2.6 1 
IV 0 6 1 7 4.8 5.8 5.7 6.7 2.6 2.6 
V 0 3 1 7 2.4 5.8 2.7 6.7 1.6 2.6 
VI 0 6 1 4 4.8 3.4 5.7 3.7 2.6 1.6 
                                                                                                                                                                                                      
Table A3.3.6. Power estimates with (m,n) = (20,20) 
Pattern t Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.869 0.868 0.849 0.757 0.745 0.755 0.698 0.834 0.848 0.752 0.839 0.834 
II 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
III 1.000 1.000 0.979 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
IV 0.227 0.226 0.500 0.499 0.482 0.494 0.437 0.537 0.547 0.495 0.537 0.533 
V 0.995 0.995 0.979 1.000 1.000 1.000 1.000 0.999 1.000 1.000 1.000 1.000 
VI 0.516 0.512 0.818 0.996 0.995 0.996 0.950 0.976 0.985 0.976 0.988 0.988 
 
Table A3.3.7. Power estimates with (m,n) = (20,40) 
Pattern t Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.947 0.944 0.936 0.881 0.875 0.881 0.858 0.925 0.932 0.857 0.921 0.918 
II 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
III 1.000 1.000 0.991 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
IV 0.284 0.253 0.627 0.609 0.598 0.609 0.619 0.677 0.675 0.638 0.656 0.656 
V 1.000 1.000 0.999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
VI 0.682 0.555 0.880 1.000 1.000 1.000 0.989 0.996 0.999 0.994 0.999 0.999 
 
Table A3.3.8. Power estimates with (m,n) = (40,20) 
Pattern T Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.948 0.942 0.937 0.888 0.882 0.888 0.865 0.927 0.935 0.864 0.927 0.923 
II 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
III 1.000 1.000 0.999 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
IV 0.288 0.299 0.614 0.686 0.677 0.686 0.608 0.654 0.692 0.601 0.696 0.689 
V 0.999 0.996 0.990 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
VI 0.589 0.717 0.943 0.999 0.999 0.999   0.995 0.998 0.998 0.997 0.997 0.998 
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A3.4 Size and power for λ=0.05 
 
H0 patterns (δ=0) 
Table A3.4.1. Characteristics of X and Y distributions  
Pattern m11 m12 m21 m22 M1 M2 MED1 MED2 σ1 σ2 
I 0 0 0 0 0 0 0 0 1 1 
IV 0 3 0 3 2.8 2.8 2.9 2.9 1.2 1.2 
IV 0 6 0 6 5.7 5.7 5.9 5.9 1.6 1.6 
                                                                                                             
Table A3.4.2. Size estimates with (m,n) = (20,20)                                                             
Pattern t Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.053 0.053 0.052 0.055 0.051 0.055 0.037 0.055 0.056 0.059 0.054 0.054 
IV 0.049 0.049 0.052 0.054 0.050 0.055 0.038 0.056 0.056 0.058 0.054 0.053 
IV 0.046 0.044 0.052 0.054 0.050 0.054 0.038 0.056 0.055 0.058 0.053 0.052 
 
Table A3.4.3. Size estimates with (m,n) = (20,40)                                                                                                       
Pattern t Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.053 0.054 0.050 0.048 0.045 0.049 0.041 0.051 0.051 0.052 0.052 0.051 
IV 0.047 0.047 0.047 0.049 0.046 0.049 0.041 0.051 0.050 0.049 0.046 0.046 
IV 0.042 0.047 0.047 0.049 0.046 0.049 0.041 0.051 0.050 0.049 0.045 0.045 
 
  Table A3.4.4. Size estimates with (m,n) = (40,20)                                                                                                                                                                                               
Pattern t Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.049 0.048 0.046 0.047 0.044 0.047 0.044 0.050 0.048 0.051 0.04 0.048 
IV 0.049 0.049 0.046 0.051 0.048 0.051 0.043 0.049 0.050 0.049 0.049 0.049 
IV 0.047 0.050 0.047 0.050 0.048 0.050 0.043 0.050 0.050 0.050 0.049 0.048 
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H1 patterns (δ=1) 
 
Table A3.4.5. Characteristics of X and Y distributions  
Pattern m11 m12 m21 m22 M1 M2 MED1 MED2 σ1 σ2 
I 0 0 1 1 0 1 0 1 1 1 
II 0 0 1 7 0 6.7 0 6.9 1 1.6 
III 0 6 1 1 5.7 1 5.9 1 1.6 1 
IV 0 6 1 7 5.7 6.7 5.9 6.9 1.6 1.6 
V 0 3 1 7 2.8 6.7 2.9 6.9 1.2 1.6 
VI 0 6 1 4 5.7 3.8 5.9 3.9 1.6 1.2 
                                                               
   Table A3.4.6. Power estimates with (m,n) = (20,20) 
Pattern t Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.869 0.868 0.849 0.757 0.745 0.755 0.698 0.834 0.848 0.752 0.839 0.834 
II 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
III 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
IV 0.510 0.507 0.754 0.680 0.666 0.678 0.635 0.761 0.763 0.669 0.735 0.721 
V 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
VI 0.942 0.939 0.998 0.999 0.998 0.999 0.997 1.000 1.000 0.998 0.999 0.999 
 
Table A3.4.7. Power estimates with (m,n) = (20,40) 
Pattern t Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.947 0.944 0.936 0.881 0.875 0.881 0.858 0.925 0.932 0.857 0.921 0.918 
II 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
III 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
IV 0.603 0.621 0.878 0.804 0.794 0.804 0.810 0.880 0.877 0.798 0.829 0.825 
V 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
VI 0.981 0.954 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
                                                                                    
Table A3.4.8. Power estimates with (m,n) = (40,20) 
Pattern t Welch WMW PG2 C C.emp KS CvM AD ZK ZC ZA 
I 0.948 0.942 0.937 0.888 0.882 0.888 0.865 0.927 0.935 0.864 0.927 0.923 
II 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
III 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
IV 0.623 0.604 0.867 0.840 0.833 0.840 0.813 0.875 0.882 0.795 0.862 0.848 
V 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
VI 0.985 0.995 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 1.000 
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Appendix 4. Real data example: exemplificative kernel 
density distributions of selected ‘gray-zone’ genes in ER 
positive (in red) and ER negative (in green) subjects 
 
 
Figure A4.1. Exemplificative density distributions of 9 genes (out of 36 features) separately identified by the WMW 
test. 
 
 
 
Figure A4.2. Exemplificative density distributions of 9 genes (out of 137 features) separately identified by the PG2 
test. 
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Figure A4.3. Exemplificative density distributions of 9 genes (out of 113 features) separately identified by the AD 
test. 
